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Colorectal cancer is the third most common cancer worldwide, with an estimated
1.36 million new cases and 694,000 deaths recorded in 2012. This number is
expected to increase by 80% reaching approximately 2.4 million cases in 2035, and
contributing to 1.3 million deaths globally per year.
In Malaysia, colorectal cancer is the second most common cancer, in both men and
women, behind lung cancer in men and breast cancer in women respectively. The
most recent estimate gives the incidence of colorectal cancer in Malaysia as 21.3
cases per 100,000 population and 9.8 deaths per 100,000 population for the six
years period reported between 2008 and 2013. The incidence of colorectal cancer
is known to vary by place and by time period. However, most research on the
spatial and variation in cancer incidence has taken place outside South East Asia,
and such research on this is still scarce in Malaysia. The research presented in this
thesis investigates individual factors affecting survival, and the spatial variation
in incidence and survival of colorectal cancer in Malaysia. This has not been done
before in Malaysia.
There are three objectives addressed in this thesis: (1) to investigate the individual
characteristics that affect survival of colorectal cancer in Malaysia, (2) to investi-
gate and model the spatial variation of survival in colorectal cancer in Malaysia,
(3) to investigate and model the spatial variation in the incidence of colorectal
cancer in Malaysia.
The research was involved 4412 of colorectal cancer patients in Malaysia with
histologically verified primary colorectal cancer who were diagnosed between 2008
and 2013 (ICD-10, C18-C20), recorded in the database of National Cancer Patient
Registry- Colorectal Cancer (NCPR-CC) Malaysia. We investigated the effect of
individual characteristics such as age, gender, education as well as clinical charac-
teristics such as cancer staging, cancer site and treatment modalities on survival
prognosis after a diagnosis of colorectal cancer using a Cox regression model. The
analysis was then been extended to model the spatial variation in survival for col-
orectal cancer patients in Malaysia, accounting for individual and socioeconomic
characteristics using a spatial survival model. We then applied a Generalized Lin-
ear Mixed Effects model, which is derived from the log-Gaussian Cox Process, in
order to model the incidence of colorectal cancer in Peninsular Malaysia.
Our findings show that the severity of disease at diagnosis as measured by cancer
staging, tumour grading and the presence of distant metastases, plays an important
role in the prognosis of patients with colorectal cancer in Malaysia, and that this
remains even after controlling for spatial correlation on space. Our research allows
us to shows the geographical variation in survival of colorectal cancer in Malaysia,
and what variation persists once individual and socioeconomic characteristics are
taken into account. Our model that developed to predict the colorectal cancer
incidence found that that some places had greater risk of an incidence exceeding the
national average. The map for probability of exceedance relative risk of colorectal
cancer incidence in the North West of Peninsular Malaysia shows variation in
the risk for colorectal cancer cases across the region. We noted that town areas
are highly likely to exceed the threshold of relative risk of increased number of
colorectal cancer cases, and this effect is present even though we account for the
additional population there.
Spatial variation in survival and incidence of colorectal cancer in Malaysia needs
to be investigated further. To the best of our knowledge, this is the first research
that uses spatial modelling to identify potential factors affecting the incidence and
survival for colorectal cancer in Malaysia, as well as to map the risks in survival
and incidence. Our findings can help public health authorities to plan better
management of the resources used to prevent and treat this disease.
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Study setting and population
This chapter describes the study setting and data source of this research. We
begin by explaining the rationale of the study, then state our aims and objectives
and outline the design of the study. Next we give an overview of the background
of our research population and explain the source of our data; we lastly detail the
ethical clearance of this research.
1.1 Rationale of the study
One of the major aims of population-level cancer research is to improve survival
prognoses for patients. A patient’s survival may depend on several known and un-
known factors. Factors influencing the survival and incidence of colorectal cancer
could be individual characteristics and/or environmental attributes of the places
where patients live. While environmental and social factors affecting the variation
in cancer incidence and survival rates have been broadly investigated, research
specific to Malaysia is still scarce.
To address this issue, we will use advanced techniques in spatial survival analysis
to model and interpret the spatial variation in colorectal cancer survival prognosis
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across the whole of Malaysia, and evaluate the role of individual, environmental
and socioeconomic risk factors within this context. We will use these spatial
models to investigate the potential factors affecting incidence, and predict the
incidence of colorectal cancer in Peninsular Malaysia. Our study will also derive
risk maps from the models.
To the best of our knowledge, this is the first cancer research in Malaysia that
utilises spatial modelling methods and maps incidence and survival risks, thus it
would represent a novel contribution to the scientific study of colorectal cancer
there.
The output in this part of the proposed research when disseminated through
peer-reviewed journal articles (currently in preparation), conferences and presen-
tations, will be of great interest to public health practitioners and epidemiologists
in Malaysia and more widely, especially those involved in providing effective in-
tervention and preventive health programmes.
1.2 Objectives of the study
1. To investigate the individual characteristics that affect survival in colorectal
cancer patients in Malaysia,
2. To investigate and model the spatial variation in survival of colorectal cancer
in Malaysia,
3. To investigate and model the spatial variation in incidence of colorectal can-
cer in Peninsular Malaysia.
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1.3 Study Design
This study was a retrospective record review study where the data was sourced
from the database maintained by the Malaysian National Cancer Patient Registry
(NCPR). The inclusion criteria for our study were as follows :
• All patients with histologically verified primary colorectal cancer who were
diagnosed between 2008 and 2013 (ICD-10, C18-C20) in the database of
National Cancer Patient Registry - Colorectal Cancer (NCPR-CC),
• Malaysian citizenship.
1.4 Study population and data sources
1.4.1 Background of Malaysia
Figure 1.1: Malaysia by states (Department of Statistics Malaysia, 2016)
Malaysia is a country in South East Asia located between 2 and 7 degrees north of
the Equator. It comprises 13 states and 3 Federal Territories, namely: Selangor,
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Perak, Kedah, Kelantan, Perlis, Penang, Terengganu, Pahang, Johor, Malacca,
Negeri Sembilan, and the Federal Teritory of Kuala Lumpur and Putrajaya in
Peninsular Malaysia, while Sabah, Sarawak and the Federal Territory of Labuan
are in East Malaysia (Figure 1.1). To the North of Peninsular Malaysia is Thailand,
while its Southern neighbour is Singapore (Department of Statistics Malaysia,
2016).
Peninsular Malaysia is separated from the states of Sabah and Sarawak (East
Malaysia or the Borneo island) by the South China Sea. Sarawak is located in
the southwest of the island of Borneo and Sabah is located in the north. The
Federal Territory of Labuan is an island located west of Sabah. Sabah and Sarawak
bounded to the south by Indonesia. Sarawak also shares a border with Brunei.
The states of Malaysia are divided into 144 administrative districts and 837 sub-
districts, also known as ‘mukim’ for the whole of Malaysia.
The population of Malaysia in 2016 was estimated to be 31.6 million, comprising
16.3 million men and 15.3 million women. Among Malaysian citizens, ethnic Bu-
miputra (Malay and indigenous) made up the greatest percentage of the population
with 68.6%, followed by Chinese (23.4%), Indian (7.0%) and Other Nationalities
(1.0%). The percentage of the Malaysian population who are non-citizens was
10.3% (Department of Statistics Malaysia, 2016).
1.4.2 Healthcare system in Malaysia
Healthcare in Malaysia is provided by two sectors; the government sector and the
private sector. There are two types of hospitals run by the government. Public
hospitals, which are run by the Ministry of Health and university hospitals run by
the Ministry of Higher Education. University hospitals are affiliated to universities.
University hospitals provide healthcare service to the public as well as serve as
teaching hospitals for the students from the universities they are affiliated with.
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The Malaysian healthcare system mainly consists of tax-funded government-run
universal services. The public sector health services are organized under a civil
service structure and are centrally administered by the Ministry of Health. In
Malaysia, the public sector provides about 82% of in-patient care and the private
sector provides about 18% of in-patient care.
The private health sector provides health services, mainly in urban areas, through
physician clinics and private hospitals with a focus on curative care. Private
companies run diagnostic laboratories and ambulance service (Safurah et al., 2013).
The cost for a visit to the government or university outpatient clinic s at polyclin-
ics, district hospitals and tertiary hospitals is just 1.00 RM (Ringgit Malaysia) for
non-specialist treatment and RM 5.00 to RM 30.00 for specialist treatment. No
charge for patients admitted in 3rd class ward, RM 5.00 charged for 2nd class and
RM 10.00 for 1st class. University hospitals also have the same fees as they are
also public hospitals but under Ministry of Higher Education . All these charges
are applicable for Malaysians only. Other costs for special services and investiga-
tions can be found in the Ministry of Health website (Ministry of Health Malaysia,
2013a)
1.4.3 Primary care referral for symptoms of colorectal can-
cer carcinoma in Malaysia
At present, there is no national population-based screening for colorectal cancer
in Malaysia. Patients who initiate a health check or present with sypmtoms are
screened and this is mainly done in the primary care setting in any government
or university outpatient clinic or polyclinic, district hospitals or tertiary hospi-
tals. In an attempt to improve early detection of colorectal cancer, various efforts
have been made to establish colorectal cancer screening programme nationally in
primary care setting.
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The first clinical practice guideline on colorectal cancer management has been pro-
duced by (Ministry of Health Malaysia, 2017) consists of a comprehensive strategy
of screening, diagnosis, staging, appropriate treatment and follow-up. Based on
clinical practice guidelines management of colorectal cancer, the screening of col-
orectal cancer should be offered at the age of 50 years and continue until 75 years
old for average risk population. Patients that comes to the health centres will be
assessed for any symptoms of colorectal cancer. Patients with symptoms will be
examined further with certain criteria and will be referred for colonoscopy (urgent
referral within two weeks or referred for elective colonoscopy). This depends on
the clinical presentation during examination. For those without symptom, they
will be stratified based on risk assessment based on the family history as average
risk, moderate risk and high risk. Average risk group will undergo Immunofaecal
Occult Blood Testing (IFOBT) and positive results will be referred for colonoscopy
testing. If negative , they will be suggested to repeat IFOBT yearly. On the other
hand, those with moderate and high risk family history of colorectal cancer will
straight away be referred for colonoscopy. As for now, this is the guideline used
by the Ministry of Health Malaysia for assessing colorectal cancer in Malaysia.
1.4.4 Collection of CRC Data in Malaysia
There are two national cancer registries in Malaysia: the National Cancer Registry
(NCR) and the National Cancer Patient Registry (NCPR). Both are managed by
the Ministry of Health; the NCR is administered by the Disease Control Division
and the NCPR by the National Institute of Health (Ministry of Health Malaysia,
2013b, National Cancer Patient Registry, 2009).
The NCR captures data on diagnoses from all regions in Malaysia. Diagnoses are
reported to a state registry and from thence to the National Registry. However,
reporting of cases to the state registries from hospitals is voluntary and therefore
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is not always completed. The Registry is not passive, though; it conducts active
case finding and routine checks. Assessment of the completeness of registration in
the NCR is difficult because it is not clear how many of the 165 main hospitals
in Malaysia are sending records to the registry, or how accurately diagnoses have
been recorded even when they were sent (Omar and Ibrahim Tamin, 2011).
The NCPR collects data on registrations of cancer from participating sites. These
participating sites are 34 hospitals that diagnose and treat cancer patients in
Malaysia. The objectives of the Registry are to describe the natural history of
cancers and to determine the effectiveness of treatments, to monitor safety, and
to evaluate access to treatments. The Registry collects data on four cancers:
colorectal cancer, blood cancers, breast cancer and nasopharyngeal cancers. The
Registry records diagnoses and collects clinical data on risk factors, treatments
and patient outcomes. This makes the NCPR data useful for research into the
effects of treatments and survival from cancers (Hassan et al., 2014).
This study using the data from the National Cancer Registry-Colorectal Cancer
(NCPR-CRC). This registry was funded by the Ministry of Health Malaysia.Registration
of cases were made through the online website (https://app.acrm.org.my/ccd). All
data were stored in a secure database with restricted access to authorised persons
only. For each source data provider, different persons are responsible for data
entry. It may consist of surgeon/Gastroenterologist, research officers, medical of-
ficers, and also trained allied health personnel (nurses and medical assistants).
This registry was registered and approved in the National Medical Research Reg-
ister and was ethically approved by the Medical Research Ethics Board, Malaysia
in 2007. It conforms to the Declaration of Helsinki which protects and uphold the
rights of all subjects in research.
For data quality control, NCPR-CRC continuously cross check their data with
National Cancer Registry (NCPR?S mother registry) to capture any missing cases.
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They also do cross checking with pathology department from respective Hospitals.
Data cleaning was also conducted time to time depending on the necessity.
Appendix 1.4.4.1 stated the data fields collected by NCPR-CRC. Date of diagno-
sis of colorectal cancer refers to the first date of confirmed biopsy of the patients
from pathology report. If pathology report is unavailable, then clinical basis will
be used for confirmation. Meanwhile, treatments data refer to any kind of treat-
ments that the patients received after he/she was confirmed diagnosis of colorectal
cancer. Any death in colorectal cancer patients were cross checked and confirmed
with Jabatan Pendaftaran Negara (National Registration Department, Ministry
of Home Affairs) by using identification number of the patients.
NCPR-CRC estimates that the overall completeness of the data was around 70%.
However, how does the completeness of data varies across areas, race, age group
or other variables were not identified at the present.
1.4.4.1 Ethical Clearance
The colorectal cancer data analysed in this study is sourced from the database
recorded by the Malaysian National Cancer Patient Registry - Colorectal Cancer
(NCPR-CC). We obtained ethical clearance from the Ministry of Health Medical
Research Ethical Committee (MREC), Malaysia, the Economic Planning Unit
(EPU), Malaysia, and from the Faculty of Health and Medicine Research Ethics
Committee (FHMREC), Lancaster University.
The main ethical consideration in this study is that of access to the patient’s confi-
dential medical data as recorded in the database. Data collection was anonymised
and was kept confidential by the researcher. In order to get a good level of spa-
tial resolution whilst preserving anonymity, only the name of patients ‘mukim’
and postcode (in Malaysia, the postcodes cover much larger areas than in the
UK) was extracted from the address. We stored a copy of the original data in
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a secure encrypted network research folder set up by Lancaster University’s ISS
team. The principal researcher’s version of the data was stored in a personal file
space electronically encrypted with a security password. The data was transferred
electronically from the National Cancer Patient Registry to Lancaster Univer-
sity in encrypted form using the University’s ZendTo secure file transfer service
(http://zendto.lancs.ac.uk/).
This thesis presents research done to investigate the factors affecting, and spatial
variation in, the survival and incidence of colorectal cancer in Malaysia. Here I
give an overview of the thesis’ structure.
We have divided the thesis into six chapters. The first chapter, Chapter 1, explains
the setting of our study, the population and data chosen for this research, and
states our investigative objectives. Then we present a review of the epidemiological
literature concerning colorectal cancer and its incidence and survival in Chapter
2.
The three objectives in this study are presented individually in Chapters 3, 4 and
5. Each of these chapters includes introductory, methods, results and discussion
sections.
Finally, in Chapter 6, we provide a general summary of the findings of all ob-
jectives investigated in this thesis, as well as a discussion and some concluding
comments on these findings. We also suggest areas that have potential for fur-
ther epidemiological and methodological research. References and appendices are





Department of Statistics Malaysia (2016). Malaysia at a glance.
https://www.dosm.gov.my/v1/index.php?r=columncone&menu id=
ZmVrN2FoYnBvZE05T1AzK0RLcEtiZz09.
Hassan, M. R. A., Khazim, W. K. W., Mustapha, N. R. N., Said, R. M., Tan,
W. L., Suan, M. A. M., and Soelar, S. A. (2014). “The Second Report of the
National Cancer Patient Registry-Colorectal Cancer, 2008-2013.” Technical re-
port, National Cancer Patient Registry-Colorectal Cancer and Clinical Research
Centre (CRC).
Ministry of Health Malaysia (2013a). Caj pesakit luar. http:http://www.moh.gov.
my/index.php/pages/view/162.
Ministry of Health Malaysia (2013b). Disease control division. http://www.moh.
gov.my/english.php/pages/view/436.
Ministry of Health Malaysia (2017). “Clinical Practice Guideline: Management of
Colorectal Carcinoma.” Technical report, Malaysian Health Technology Assess-
ment (MaHTAS).
National Cancer Patient Registry (2009). The national cancer patient registry.
http://www.acrm.org.my/ncpr/.
Omar, Z. A. and Ibrahim Tamin, N. (2011). “National Cancer Registry Report
Malaysia Cancer Statistics Data and Figure 2007.” Malaysia: National Cancer
Registry, pages 85–7.
Safurah, J., Mohd Noh, K., Othman, N. H., and Healy, J. (2013). “Malaysia Health




The chapter begins by providing a clinical overview of colorectal cancer: its defi-
nition, the signs and symptoms, how it is investigated and diagnosed, and clinical
staging. Section 2.3 in this chapter considers the burden of colorectal cancer; its
incidence and mortality rates worldwide, in all Asian countries, in South-East Asia,
and then finally in Malaysia particularly. The latter section provides general infor-
mation about Malaysia’s geographical and population characteristics, and current
published rates of colorectal cancer. Sections 2.4 to 2.6 provide a review of previ-
ous studies into survival and prognostic factors for patients with colorectal cancer.
Section 2.7 examines previous survival studies for colorectal cancer in Malaysia.
2.2 Clinical Overview of Colorectal Cancer
This section describes the anatomy of the colon and rectum, and defines colorectal
cancer together with its clinical features, diagnosis, symptoms and staging.
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2.2.1 Anatomy of the Colon and Rectum
The system responsible for processing food and nutrients in our body is known
as the digestive system or gastrointestinal tract. It has two main parts, the small
intestine and the large intestine. The colon and rectum are part of the large
intestine. The colon is shaped like a tube and measures about 5 feet in length.
It is divided into the ascending colon, the transverse colon, the descending colon
and the sigmoid colon. Fecal material matter in the colon moves gradually under
peristalsis to the rectum, which is the last 6 inches of the large intestine and passes
out from the body through the anus. (American Cancer Society, 2014)
Figure 2.1: Human Anatomy: the Digestive System
2.2.2 Definition of Colorectal Cancer
Colorectal cancer refers to cancer in the colon or rectum. Cancer starts out as
small growths occurring in the mucosal layer of the colon. These small growths are
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known as polyps; they are benign (non-cancerous). Over a few years, the polyps
may grow to become malignant (cancerous) tumours referred to collectively as
colorectal cancer. (American Cancer Society, 2014).
2.2.3 Signs and symptoms
The presenting symptoms of colorectal cancer vary depending on the site of the
cancer and stage of the disease. Patients may present with symptoms of alteration
in bowel habit, intestinal obstruction, pain with an abdominal mass, unexplained
reduction in weight, the presence of blood in the stool, or anaemia (Sack and
Rothman, 2000). These symptoms may not be noticed by the patient for a long
time.
Patients with colorectal cancer in the right side of the colon usually have symptoms
of anaemia, loss of weight or abdominal pain. Patients with cancer in the left side
of the colon often have an alteration in bowel habit or rectal bleeding (Simpson
and Scholefield, 2008). Hamilton et al. (2005) determined that rectal bleeding,
loss of weight, number of episodes of abdominal pain, constipation and number
of episodes of diarrhoea were the five significant features most associated with
colorectal cancer before diagnosis.
A systematic review conducted by Astin et al. (2011) on 23 works investigating
symptoms of colorectal cancer reported that rectal bleeding is a major symptom of
the disease. The review reported that an individual will be most at risk of having
colorectal cancer if they have symptoms of rectal bleeding together with alteration
in bowel habit and loss of weight.
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2.2.4 Investigation and Staging for Colorectal Cancer
Colorectal cancer can be diagnosed by investigative procedures such as colonoscopy,
flexible sigmoidoscopy, double contrast barium enema and CT scan. The primary
investigative procedure for colorectal cancer is colonoscopy. A biopsy sample is
taken from the colon and sent to the histopathology laboratory to confirm the
diagnosis. CT scan can be used to assess cancer staging (Dorundi and Bannerjea,
2008).
Cancer staging shows the extent of the disease and how far it has spread. The
cancer staging in this study is based on the TNM staging system. According
to Greene et al. (2002), the T refers to the depth of the tumour, N refers to
the number of lymph nodes that are involved and M refers to the occurrence of
metastases.
2.2.5 Treatment for colorectal cancer
Treatment for colorectal cancer depends on the stage and location of the cancer, as
well as the risks and benefits associated with the treatment themselves.. Surgery
to remove the tumour tissue is the main treatment for colon cancer . Adjuvant
therapy (additional ,which is the addition of treatment after surgery may also be
involved depending on the severity of the disease , for example if the cancer is
likely to come back of show growing into other tissues(American Cancer Society,
2014). For rectal cancer, surgery is also chosen as the main treatment. Additional
treatments, such as chemotherapy and radiation, are often used before surgery
(neo-adjuvant therapy) and/or after surgery (adjuvant therapy) to reduce the risk
of recurrence and metastasis. If the cancer has spread through the wall of the
rectum into nearby tissue and/or lymph node (regional stage), the radiation and
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chemotherapy are often given together before surgery, with additional chemother-
apy often given after surgery. The chemotherapy drugs used in the treatment of
rectal cancer are the same as those used for colon cancer. 5-fluorouracil (5-FU)
capecitabine, oxal- iplatin, and irinotecan are the chemotherapy drugs that most
often used in the treatment of colorectal cancer (American Cancer Society, 2014).
In late stage colorectal cancer, where the cancer has spread to distant organs and
tissues such as the liver, lung, peritoneum (lining of the abdomen), or ovaries,
not all patients will be recommended for surgery. Chemotherapy, radiation, and
biologically targeted therapies may be given alone or in combination to relieve,
delay, or prevent symptoms and to prolong survival of the patients (American
Cancer Society, 2014).
2.3 Incidence and Mortality Rates of Colorectal
Cancer
2.3.1 Worldwide
The incidence and mortality data reported in this section were extracted from
the GLOBOCAN 2012 report (Ferlay et al., 2014). This GLOBOCAN data was
presented by type of region, classed as either developed or less developed regions.
Countries in more developed regions include North America, Europe, Australi-
a/New Zealand and Japan. The incidence and mortality rates given are Age
Standardized Rates (ASR), defined in the GLOBOCAN (Ferlay et al., 2014) re-
port as ‘a summary measure of the rate that a population would have if it had a
standard age structure using World standard population, expressed as per 100,000
persons per year.
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Cancer is a major health burden across the world, with over 14.1 million new
cancer cases worldwide in 2012. Of these, around 1.35 million cases (9.6%) are
new cases of colorectal cancer. The number of colorectal cancer cases is expected
to increase by 80% by the year 2035, climbing to approximately 2.4 million new
colorectal cancer cases and contributing to 1.3 million deaths worldwide (Douaiher
et al., 2017). Colorectal cancer also is the third most common cancer in men and
the second most common cancer in women (Ferlay et al., 2014).
For the past three decades(1975 to 2010), there was an increasing trend of colorec-
tal cancer incidence world wide ranging from 100 to almost 400 cases per 100,000
population per year and the trend was found to be higher in men (Ferlay et al.,
2014). The increasing trend of colorectal cancer incidence worldwide was projected
to continue for the next 25 years.
In 2012, the estimated number of deaths from colorectal cancer was 690,000 world-
wide, of which 53.8% and 46.2% were in men and women respectively. In the same
year, the worldwide mortality rate for colorectal cancer was 8.4 deaths per 100,000
(10.0 per 100,000 in men and 6.9 per 100,000 in women). Though incidence is
higher in developed regions in 2012, mortality rates attributable to colorectal can-
cer were higher in less developed regions, accounting for 52% of total colorectal
cancer deaths worldwide (Ferlay et al., 2014).
2.3.2 Asian countries
In the GLOBOCAN (GLOBOCAN, 2012) report, Asia is divided into four regions:
Eastern Asia, South-Eastern Asia, South-Central Asia and Western Asia. Lung
cancer is the most-diagnosed cancer in Asia with an estimated 1.04 million new
cases in 2012 (15.5% of all cancer cases). This is followed by stomach cancer
(10.4%), breast cancer (9.6%) and colorectal cancer (9%); the latter of which
represents an estimated 607,200 new cases in Asia in 2012, 347,500 cases in men
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and 259,700 cases in women. This makes it the fourth most common cancer in
all of Asia. The incidence of colorectal cancer in Asia was 13.7 cases per 100,000
population per year, comprising male and female incidence of 16.5 and 11.1 per
100,000 population per year respectively. 69% (421,400) of these estimated new
Asian cases of colorectal cancer were in Eastern Asia, with 18.4 cases per 100,000
population per year. This information is presented in Table 2.1.
There were an estimated 331,600 deaths from colorectal cancer in Asia in 2012,
of which 185,000 deaths were men and 146,600 deaths were women. The ASR
mortality was 7.2 per 100,000 population per year, with 8.6 and 6.0 per 100,000
population per year in men and women respectively. The highest estimated num-
ber of deaths was in Eastern Asia, whose 207,700 deaths represent 62.6% of all
deaths from colorectal cancer in Asian countries (Ferlay et al., 2014), as presented
in Table 2.2. Figure 2.2 and Figure 2.3 show the maps of incidence of and mortality
due to colorectal cancer in Asia.
Overall, there was an upward trend in colorectal cancer incidence in Asian coun-
tries for the past three decades(1975-2010). Countries with the highest inci-
dence trends are Japan, China and Singapore from EastAsia and South-East Asia
while colorectal cancer incidence in Thailand(South-East Asia) and India(South-
Central) Asia are at the bottom two. In many low-income and middle-income
countries, CRC incidence and mortality rates correlates with the adoption of a
western lifestyle linked to ongoing societal and economic development. In highly
developed countries, rates are stabilising or decreasing (Arnold et al., 2016a).
Table 2.1: Estimated number of new colorectal cancer cases (thousands) in
Asia in 2012
Region Male (%) Female (%) Total (%)
Eastern Asia 243.2 (70.0) 178.2 (68.7) 421.4 (69.4)
South-Eastern Asia 38.5 (11.1) 30.5 (11.7) 69.0 (11.4)
South-Central Asia 50.7 (14.6) 39.0 (15.0) 89.7 (14.8)
Western Asia 15.1 ( 4.3) 12.0 ( 4.6) 27.1 ( 4.4)
Total 347.5 (100) 259.7 (100) 607.2 (100)
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Table 2.2: Estimated number of colorectal cancer deaths (thousands) in Asia
in 2012
Region Male (%) Female (%) Total (%)
Eastern Asia 115.5 (62.4) 92.2 (62.9) 207.7 (62.6)
South-Eastern Asia 24.1 (13.0) 19.1 (13.0) 43.2 (13.0)
South-Central Asia 37.0 (20.0) 28.4 (19.4) 65.4 (19.7)
Western Asia 8.4 ( 4.6) 6.9 ( 4.7) 15.3 ( 4.7)






Figure 2.2: Map of Asia showing Age Standardized Rate of Incidence of Col-
orectal Cancer in Asia
*see text for definition of Age Standardized Rate (ASR)
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Figure 2.3: Map of Asia showing Age Standardized Rate of Mortality due to
Colorectal Cancer in Asia
*see text for definition of Age Standardized Rate (ASR)
2.3.3 South-East Asian Countries
This area comprises Malaysia and its closest surrounding countries; namely Brunei,
Cambodia, Indonesia, Laos, Myanmar, Philippines, Singapore, Thailand, Timor
Leste and Vietnam. GLOBOCAN estimated that there were 68,900 new cases of
colorectal cancer in South-East Asia in 2012. Of that number, an estimated 38,500
cases were in men and 30,400 in women. The age standardised rate of colorectal
cancer incidence in South-East Asia was 12.5 cases per 100,000 population per
year; 15.2 in men and 10.2 in women (Ferlay et al., 2014). According to the
GLOBOCAN report, Singapore, which is adjacent to Malaysia, had the highest
age standardized incidence rate of this group of countries, at 33.70 per 100,000
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population per year. The Singapore Registry Report 2009 (Peng et al., 2013)
stated that colorectal cancer was the most common cancer among males between
2009 to 2013 and the second most common cancer in females; representing 17.3%
and 13.2% of all cancer cases in males and females respectively (Peng et al., 2013).
Malaysia had the third highest estimated incidence in 2012 among South-East
Asian countries with an incidence of 13.4 cases per 100,000 population; Figure 2.4
(Ferlay et al., 2014).
In South-East Asia, the estimated number of deaths attributed to colorectal cancer
in 2012 was 43,200 cases, of which, 24,100 deaths were men and 19,100 women.
The estimated age standardised mortality rate for colorectal cancer in South-East
Asia was 7.9 deaths per 100,000 population overall with 9.7 and 6.4 ASR deaths
per 100,000 population in men and women respectively. Brunei had the highest
mortality rate attributed to colorectal cancer in 2012 with 12.0 deaths per 100,000
population while Malaysia had 9.4 deaths per 100,000 population (Ferlay et al.,
2014). However, the incidence and mortality data from GLOBOCAN was based
on data obtained from only two states (Penang and Sarawak) in Malaysia and not
from the other 12 states. More detail is given in the next section.
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Figure 2.4: Plot of age standardized rates of incidence and mortality of
colorectal cancer in South-East Asia, taken from the GLOBOCAN website
(GLOBOCAN, 2012)
2.3.4 Malaysia
In Malaysia, cancer is one of the leading causes of mortality; the Ministry of Health
in Malaysia reports cancer as the third leading cause of death after heart disease
and disease of pulmonary circulation, and septicaemia (Omar and Ibrahim Tamin,
2011).
Colorectal cancer ranks as the second most common cancer in Malaysia for both
sexes; exceeded only by lung cancer in men and breast cancer in women. The
2nd Annual Report by the National Cancer Patient Registry - Colorectal Cancer
reported that the cumulative incidence rate was 21.3 cases per 100,000 popula-
tion between 2008 and 2013 (Hassan et al., 2014). 55.9% of the overall cases
were men. Grouping the population by ethnicity, Malay (42.7%) had the most
colorectal cancer cases reported, followed by Chinese (40.3%), Indian (5.8%) and
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Other Ethnicity (10.8%); after accounting for age, having Chinese ethnicity cor-
responded to the highest Age Standardized Rates of colorectal cancer incidence
with 27.4 cases per 100,000 population. The Age Standardized Incidence Rates
for Malay and Indian ethnicities was 19.4 and 17.6 cases per 100,000 population
respectively (Hassan et al., 2014).
The mortality rate from 2008-2013 was 9.8 cases per 100,000 population. Among
the three largest ethnic groups, the highest proportion of deaths was among Malay
(49.2%), followed by Chinese (42.3%) and Indian (39.4%). Like the incidence
rates above, the age adjusted mortality rate was highest among those of Chinese
ethnicity with 11.9 deaths per 100,000 population, followed by Malay and Indian
with 9.6 and 7.1 deaths per 100,000 population respectively (Hassan et al., 2014).
2.4 Survival Rates for Colorectal Cancer
Cancer is a chronic disease. How long individuals will survive depends on the
severity of the disease at diagnosis, and on other factors affecting survival time
that it is important to determine. Many studies have been carried out worldwide
to predict cancer survival time and identify factors affecting this including socio-
demographics, clinical factors and treatment modalities.
A recent study noted that incidence and mortality rates for colorectal cancer vary
widely worldwide and are associated with human development levels; in particular
where societal or cultural changes might incrementally reflect the adoption of a
more western lifestyle (Arnold et al., 2016b).
Previous research has shown that there is a trend of increasing survival of colorectal
cancer in Europe. A recent population based survival study in England and Wales
by Quaresma et al. (2015) reported that survival for colorectal cancer has been
steadily increasing over a 40 year period (1971 to 2011). The 5-year survival rate
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in this period had increased from 24.6% to 58.2% for colon cancer and 24.2%
to 59.7% for rectal cancer in England. The same trend was also found in Wales
where the 5-year survival rates increased from 25.0% to 57.7% and 22.9% to 58.5%
for colon and rectal cancers respectively (Quaresma et al., 2015). This increasing
trend may be a result of the implementation of cancer screening in 2006, which
aims to prevent invasive malignant tumours by diagnosing cancer at an early stage.
Tang et al. (2015) performed a meta analysis of four randomized controlled trials:
the study suggested that one death from colorectal cancer is prevented for every
1000 people that had been screened by flexible sigmoidoscopy.
Bujanda et al. (2010) compared the survival rates between groups of patients di-
agnosed with colorectal cancer in Spain during two separate periods of time; one
group of patients diagnosed between 1980 and 1994 and another group diagnosed
in 2001. The 5-year survival rates in these two groups were 35% and 57% re-
spectively and the difference was statistically significant, showing an increasing
trend in 5-year survival over 20 years. They concluded that the increased 5-year
survival trend was parallel to both an increase in the administration of adjuvant
chemotherapy and a decline in postoperative mortality (Bujanda et al., 2010). Sim-
ilarly, a systematic review and meta-analysis noted that additional chemotherapy
improved overall survival in colorectal cancer patients with liver metastases who
underwent curative resection (Araujo et al., 2015). Another study, Oliphant et al.
(2013), showed that longer term survival in the study was significantly influenced
by surgical specialisation.
Colorectal cancer survival rates also improved over time in Asian countries. A
population-based study carried out among colorectal cancer patients in China
(Fang et al., 2013) found that the overall 5-year survival rate improved throughout
the 50 year period between the 1960’s and the 2000’s, increasing from 49% in the
1960’s to 77% in the 2000’s. Fang et al. (2013) noted that it could have been
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the result of advances in surgical techniques and chemotherapy, and changes to
lifestyle.
In another study comparing the results from different pieces of research in a few
Asian countries, they concluded that the 5-year survival rate remained at almost
60%, where China had the highest and India the lowest 5-year survival rate (31.2%)
(Moghimi-Dehkordi and Safaee, 2012).
Overall, the survival rate for colorectal cancer showed an increasing trend in both
Western and Eastern countries. Individual level factors that may affect colorectal
cancer survival will be discussed in the next section.
2.5 Risk Factors for Colorectal Cancer
We searched PubMed database and Google Scholar to identify articles on colorec-
tal cancer. The search strategy combined the Medical Subject Heading (MeSH)
with search terms that include “neoplasm”, “malignancy”, “cancer”, “colon” and
“rectum”. Text word search include variations of “colorectal”, “colon”, “rectal”,
“cancer”, “tumour”, “malignant”, “prognostic”, “prognosis”, “incidence”, “risk
factor”, “survival”. Other terms is changed based on search topic. For example,
to search age as a prognostic factor, the term ¿‘Age” OR “Young” OR “Old” is
added to the existing terms. Publications were limited to human studies published
between January 2000 to December 2017 in English language. We also searched
the available national cancer registries of individual Asian countries to make a
comparison on cancer statistics
Factors that increase the risk of developing colorectal cancer can be divided into
two categories: modifiable factors and non-modifiable factors.
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Non-modifiable risk factors include having inflammatory bowel disease, some hered-
itary factors and old age (Haggar and Boushey, 2009). Wei et al. (2004) compared
risk factors for colon cancer and rectal cancer; they reported that people who have
first degree relatives with colon or rectal cancer are more at risk of getting either
of these cancers. Specifically, these patients are almost twice as likely to develop
colon cancer (RR 1.94, 95% CI (1.80 , 2.10)), and 27% more likely to develop
rectal cancer (95% CI (1.08,1.50)) than patients without family history of these
cancers.
Modifiable factors include obesity, lack of physical activity, a diet high in red
and/or processed meat, smoking, and excessive drinking of alcohol and are all
known to be associated with a diagnosis of colorectal cancer (Johnson et al., 2013).
2.6 Prognostic Factors for Colorectal Cancer
We previously mentioned that colorectal cancer is one of the primary causes of
mortality worldwide. Therefore, understanding how different factors affect the
prognosis and eventual survival of patients with this disease is of great importance.
In this section, we discuss previous research drawn from a variety of populations
studying factors that affect the survival outcomes of patients with colorectal can-
cer, and discuss several in particular that are relevant to the data we are using
in this thesis. These factors are: age, sex, race, tumour location and socioeco-
nomic status. We describe herein the effects of these factors on the survival of
colorectal cancer patients in different populations. We acknowldge that this list
is not exhaustive and there are other factors that may also affect the survival of
colorectal cancer that we do not have data for yet, such as genetic influences and
comorbidities; these are areas that might be considered in future research.
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2.6.1 Age
More than 90% of the patients diagnosed with colorectal cancer were found to
be more than 55 years old in the Li et al. (2015) study. Age at diagnosis also
affects the survival from the disease. Despite previous findings that associate
advanced age with poor survival, there are other studies that report that there is
poor outcome in younger colorectal cancer patients. Generally, colorectal cancer
in young patients usually presents with poor tumour morphology and late stage
at diagnosis compared to older individuals (Li et al., 2015, Orsini et al., 2015)
and with other factors that lead to poor survival (Chan et al., 2010, LIN et al.,
2005). Fu et al. (2014) in their 30-year (1985 to 2011) retrospective review study
in China found that age was not significant as an independent prognostic factor
for colorectal cancer after controlling for other factors including sex and clinical
and pathologic characteristics.
On the other hand, some studies found that young patients have a better survival
prognosis despite presenting with more advanced disease at diagnosis. This is es-
pecially so after surgery, compared to the elderly. This phenomenon is reported
in numerous studies worldwide, such as in the US (Li et al., 2015, 2014), Europe
(McKay et al., 2014, Widdison et al., 2011) and in Asian countries (Yeole et al.,
2001, Yuan et al., 2013). A large population-based study reported that the eldest
group of patients (> 80 years) have almost twice the risk of death after operation
with hazard ratio 1.95, 95% CI (1.90, 2.02), after controlling for other factors (Li
et al., 2015). The result is explained by a higher percentage of co-morbodities
and complications after surgery experienced by older patients. This is agreed by
Widdison et al. (2011) and Stornes et al. (2014), who claimed that age influ-
ences the selection of treatment modalities in older patients; for example, older
patients may be treated less often with surgery (including major radical surgery)
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or radio-chemotherapy, which results in more local recurrence and poorer eventual
outcomes. This suggests a more complex causal pathway.
2.6.2 Sex
Incidence of colorectal cancer is considerably higher in men than women in many
countries worldwide (Ferlay et al., 2014). Findings on the influence of sex differ-
ences in colorectal cancer prognosis have been less consistent. Some studies, for
example those by Hendifar et al. (2009), Majek et al. (2013), McArdle et al. (2003)
,report a better survival in women, while other studies did not find any signifi-
cant difference (Lydrup and Ho¨glund, 2015). An analysis of a large representative
cohort, comprising 24 clinical trials, that enrolled more than 30,000 colon cancer
patients between 1978 and 2003 found that women with early stage colon cancer
have significantly higher survival rates than men (Cheung et al., 2013). In their
review, the researchers point out that the better survival in women may be due to
their longer life expectancy on average compared to men, it is also possible that
men may have a biologically more-aggressive disease or a poorer response to ad-
juvant therapy which leads to poorer survival. However, the subset analysis when
stratified by age group showed that differences between sexes were more apparent
in the older age group (aged > 65 years) than in patients aged ≤ 65 years, with a
significant interaction (Pinteraction < 0.01).
A study by Kotake et al. (2016) focused on Asian countries. In their large study
spanning a 20 year period (1985 to 2004) and involving more than 80,000 colorectal
cancer patients in Japan, it was stated that sex is an independent prognostic factor
for survival of colorectal cancer after controlling for other factors. Women have a
lower risk of death compared to men with an adjusted hazard ratio of 0.92, 95%
CI (0.90, 0.95). Similarly, in Taiwan, Chou et al. (2013) reported that the 5-year
survival rates for colon and rectal cancer were approximately 2-5% higher in women
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than men. Similarly, in Tehran, a significant difference in 5-year survival rate was
found between the sexes, where females had better survival (75%) compared to
males (63%), and sex was also included as an independent prognostic factor in
a Cox Model (Heidarnia et al., 2013). Another study by Lydrup and Ho¨glund
(2015) found that sex had no significant influence on colorectal cancer survival
when controlling for age at diagnosis, neo-adjuvant treatment, tumour stage and
year of having surgery.
2.6.3 Race
Different races or ethnic groups may have different cultures, lifestyles, environ-
ments and food preferences, and these factors may influence their health outcomes
in general. Racial disparities have been reported to influence the survival of col-
orectal cancer in many countries (Le et al., 2009, Sabounchi et al., 2012, Veach
et al., 2014).
Chien et al. (2005) evaluated the relationship between race/ethnicity and colorec-
tal cancer outcome among 18 different racial/ethnic groups in the United States of
America involving more than 150,000 colorectal cancer patients diagnosed between
1988 and 2000. The analysis of this large nationally representative population-
based sample quantifies a significant variation in survival between ethnic groups.
Similarly, a later US study of rectal cancer patients diagnosed between 2000 and
2009 demonstrated that race was a significant prognostic factor in multivariable
analysis with a hazard ratio of 1.49 and 95% CI (1.10, 2.02) (Nitzkorski et al.,
2013). This is also consistent with a further study by Ahmadi et al. (2014) in
Asian countries which reported race as an independent prognostic factor for col-
orectal cancer patients. Conversely, Hassan et al. (2009) claims that ethnicity
was associated with different age and stage at diagnosis but did not influence the
patients’ treatment or survival outcome.
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2.6.4 Smoking
Smoking is a risk factors for many diseases including colorectal cancer. A 2014
report by the US Surgeon General (US Department of Health and Human Services
et al., 2014), concluded that smoking is a risk factors for colorectal cancer and also
that smoking is causally related to higher mortality from colon and rectal cancer.
A systematic review and meta-analysis which included 16 studies on smoking and
survival in colorectal cancer estimated a combine all cause mortality hazard of
death in current smokers to be significantly higher, at 26% (HR 1.26 (95%CI
1.14- 137) compared to non-smoker patients (Walter et al., 2014). In a later
study, Sharp et al. (2017b) investigated the association of between smoking at
diagnosis and cancer specific survival in colon cancer. In this population based
cohort study involving 18,166 colon cancer patients, it was found that smoking was
an independent prognostic factor for colon cancer. When looking at the association
between smoking status and colon cancer survival, they noted that the significant
association was found in patients with surgical treatment only and suggested that
this might be due to the underlying mechanism related to surgery. Later, they
carried out a study on the relationship between smoking and survival of 10,794
rectal cancer cases in Ireland. Current smokers with have rectal cancer were found
to have significantly poorer survival (HR=1.15, 95%CI 1.06-1.24) compared to non-
smokers but the association was not significant in the former smokers at diagnosis
of rectal cancer (Sharp et al., 2017a).
Recently, there is was a large review and meta-analysis studies of the impact of pre-
diagnostic smoking on colorectal cancer prognosis, which involved 14 population-
based cohort studies from 10 different countries in Europe and US. A significant
association was found between current smoking (HR 1.29; 95% CI ; 1.04;1.60) and
former smoking (HR 1.12; 95% CI 1.04;1.20) with poorer overall colorectal cancer
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mortality but for the cause specific mortality, the association was not significant
after adjusting for other covariates in the model (Ordo´n˜ez-Mena et al., 2017).
2.6.5 Diabetes
Previous studies reported the association between diabetes and survival in colorec-
tal cancer. In the Netherland, a study was carried out that involved almost 10,000
colorectal cancer patients diagnosed in a 10-year period(1997 and 2007). These re-
searchers found that patients with pre-existing diabetes at diagnosis had a higher
risk of death from colorectal cancer compared to non-diabetic patients even after
controlling for socio-demographic and clinical factors (Van de Poll-Franse et al.,
2012). Lower overall survival may also be attributable to poor diabetes control,
the result of a lack of attention to diabetes during cancer treatment. This latter
idea was postulated by the American Diabetes Association and American Cancer
Society in 2010 concerning diabetes and cancer (Zanders et al., 2014).
Opposite findings were found by a smaller study of 1039 colorectal cancer cases
diagnosed between 2003 to 2005 from the Italian Cancer Registries database which
indicated that diabetes in patients increased their survival. They claimed that this
might be due to prevention and treatment stabilizes the condition and controls its
complications and reduces mortality (Bella et al., 2013).
This is similar to a recent study which examined the association of four metabolic
syndrome disease characteristics (diabetes, obesity, hypertension and dyslipidaemia)
to progression-free survival in patients in with Stages I to Stages III colorectal can-
cer. Their results suggested that only diabetes mellitus had a significant positive
association with progression-free survival and they found that the use of Metformin
in the treatment of diabetic patients improved their outcome of progression free
survival (Croft et al., 2018).On the other hand, a large systematic review and
meta-analysis involving 21 eligible cohorts which involved more than one million
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patients of colorectal cancer had different findings. This meta-analysis indicates
that colorectal cancer patients with pre-existing diabetes mellitus was adversely
associated with lower(worse) overall survival. However the association was not
significant with cancer-specific survival (Li et al., 2017)
2.6.6 Site
The prognosis of colorectal cancer has been shown to vary depending on the
anatomical site of the tumour. Lee et al. (2013)’s study in the USA and Ja-
farabadi et al. (2011)’s in Iran reported that patients with cancer at the rectum
had better survival compared to those who had cancer at the colon. However,
Fang et al. (2013) found a better 5-year survival was significantly associated with
tumour location in the colon than in the rectum, among colorectal cancer cases
diagnosed between 1960 to 2008 in China.
Patients with right-side tumours have been reported to have poor prognosis com-
pared to left-side tumours in some studies (Golan et al., 2013, Meguid et al., 2008,
Powell et al., 2012). Those with right-side tumours had a 4.2% increased risk of
death (adjusted hazard ratio of 1.042 and 95% CI (1.02, 1.07)) compared with pa-
tients that had tumours on the left side of the colon, including the rectum (Meguid
et al., 2008). These findings are in the line with a recent study by Price et al.
(2015) which revealed that patients with tumours on the left side of the colon
had a 25% greater survival rate than patients with tumours on the right side of




The stage at diagnosis plays the biggest role in affecting the survival of colorectal
cancer patients. Survival times in patients with colorectal cancer vary significantly
across the different stages of the disease as has been indicated in findings by
previous studies (Chien et al., 2013, Lemmens et al., 2005, Li et al., 2014, Quah
et al., 2008). As the stage of disease at diagnosis advances, survival becomes
considerably shorter.
Aravani et al. (2009) reported that 93% of patients who presented with earlier
stage disease (Dukes A) survived longer than 5 years compared to only 6% of
those with late stage disease (Dukes D). In another study, Ghabeljoo et al. (2011)
confirmed that pathologic stage was an independent prognostic factor for both
colon and rectal cancer, where the strongest hazard of death was observed in
stage IV cancers, with hazard ratio 8.42 and 95% CI (2.09, 33.93). Conversely,
Van der Pool et al. (2011) saw a positive improvement over time in survival in
patients whose cancer was at stage IV at diagnosis, which could have been a result
of advancement in chemotherapy or the proportion of patients that had also had
liver surgery. This is in agreement with another study by Stelzner et al. (2005).
2.6.8 Socioeconomic status
Socioeconomic status has an association with colorectal cancer survival acknowl-
edged in a number of studies. Findings from Dik et al. (2014), Harris et al. (2009),
Le et al. (2008), Manser and Bauerfeind (2014) and Kelsall et al. (2009) show
that declining socioeconomic status is associated with poorer survival. The group
with the lowest socioeconomic status in Hines et al. (2014) had a 24% higher risk
of death than that of the highest socioeconomic status (hazard ratio 1.24, 95%
CI (1.16,1.32)). Hole and McArdle (2002) observed the impact of socioeconomic
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deprivation on outcome after surgery of 2269 colorectal cancer patients and found
that the lowest 5-year survival rate was in the most deprived group of patients
(30.3%) compared to 32.5% in the intermediate and 35% in the most aﬄuent
group.
The inequalities of survival may be explained by less treatment being received by
the lower socioeconomic status groups (Hines et al., 2014). Similarly, Aarts et al.
(2010) in his review of 55 articles, discussed that unfavourable results have been
seen in treatment, survival and mortality in the lower socioeconomic status groups
where these patients tend to receive neo-adjuvant therapies less frequently than
those in higher socioeconomic status groups.
Overall, evidence from literature suggests that research investigating factors af-
fecting survival in colorectal cancer in certain populations is important and may
help public health practitioners to plan and manage better healthcare.
2.7 Survival and Incidence Studies in Malaysia
In the previous section, we described various studies carried out both worldwide
and in purely Asian countries concerning the factors influencing survival in patients
with colorectal cancer. In this section we present published research on colorectal
cancer that pertains specifically to patients in Malaysia.
Ghee (2014) reviewed 56 research articles concerning colorectal cancer that were
conducted in Malaysia. They looked into genetic causes and biomarkers, KAP
(knowledge attitude and practice) studies and quality of life studies among col-
orectal cancer patients. The literature on epidemiology and survival in colorectal
cancer in Malaysia is not extensive. The most common site of colorectal cancer
was found to be the left side of the colon. Azmi et al. (2007) studied 119 patients
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who underwent surgery in one of the hospitals in Malaysia, and noted that col-
orectal cancer was more common in men and in patients of Malay ethnicity. More
than fifty percent of the cases were found to be in the recto-sigmoid junction and
rectum. In a later study, Magaji et al. (2014) investigated a larger sample involv-
ing 1212 colorectal cancer patients treated in University Malaya Medical Centre
between 2000 and 2010. Similar to previous findings, they reported more male
patients than female, but here more than 60% of the patients were Chinese.
Cancer survival in Malaysia has been studied at a regional level. A retrospective
record review study considered colorectal cancer patients diagnosed over the ten
year period from 1996 to 2005 in Hospital Universiti Sains Malaysia (HUSM) Ke-
lantan, (Ghazali et al., 2010). The study reported that the overall 5-year survival
rate was 34.3% and identified three significant independent prognostic factors:
Dukes staging at diagnosis, presence of liver metastases and treatment modalities.
Apparent delay in screening (Al-Naggar et al., 2015, Hilmi et al., 2010) and seeking
treatment (Rashid et al., 2009) in high risk groups lead to poor overall survival in
colorectal cancer patients.
Low socioeconomic groups are particularly at risk. Kong et al. (2010) investi-
gated the impact of socioeconomic class on colorectal cancer patients in two ma-
jor hospitals in Peninsular Malaysia (Kuala Lumpur) and West Malaysia (Kuch-
ing, Sarawak). Socioeconomic status was based on occupation as defined by the
National Statistics Socioeconomic Classification. Patients from a lower socioeco-
nomic class presented with later stage disease and had a smaller 5-year survival
rate. Most of the studies only performed a descriptive analysis without further
assessing the prognostic factors affecting survival in colorectal cancer.
Studies about colorectal cancer incidence in Malaysia are not extensive. One
study has estimated the cumulative incidence rate for colorectal cancer patients
diagnosed between 2008 to 2013 in Malaysia by sex and ethnicity for colorectal
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cancer reported in the report by NCPR-CRC (Abu et al., 2016). The study re-
ported that the cumulative incidence of colorectal cancer in the six year period
was 21.32 cases per 100,000 population. Males had higher cumulative incidence in
with 24.6 per 100,000 population compared to females with 18.4 cases per 100,000
population during the same period. Chinese ethnicity had the highest overall in-
cidence followed by Malay and Indian with an incidence of 27.35, 18.95 and 17.55
cases per 100,000 population respectively (Abu et al., 2016) .
Later, another study investigated the modifiable risk factors for colorectal cancer
in Malaysia. These included alcohol consumption, being overweight and physical
inactivity amongst the Malaysian population. Their analysis aimed to estimate
the population attributable fraction (PAF, the fraction of all cases (both exposed
and unexposed in a population) that would not have occurred had the exposure
not occurred. Their findings suggested that approximately 18% of the CRC cases
in the year 2013 would be preventable, if proper interventions to limit physical
inactivity, overweight and alcohol consumptions were implemented (Naing et al.,
2017).
Other studies reported the distribution of colorectal cancer cases within selected
countries. These studies, Samat et al. (2013), Samat and Shattar (2014) and Shah
et al. (2014), demonstrated the spatial pattern in colorectal cancer incidence and
mapped hot and cold spot regions. However, no spatial modelling was involved,
and only one state was chosen in each study (namely, Penang, Kelantan and Kuala
Lumpur). We reviewed these studies in the introduction section of chapter 5. We
will see later that case-ascertainment is an issue for incidence studies in Malaysia.
Socio-demographic and clinical factors are factors that affect both survival from
and incidence of the colorectal cancer. There are other factors that affect the sur-
vival and incidence such as environmental factors , for example the socioeconomic
status of the population.. We were also interested to examine the effect of where
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someone lives on survival and incidence, that is spatial factors, which we are inter-
ested in investigating in this research. To date, this is the first study looking into
spatial variation in survival and the incidence of colorectal cancer for the whole
Malaysian population, a research gap this thesis seeks to fill.
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Chapter 3
The Effect of Individual-Level
Factors in Survival Prognosis for
Colorectal Cancer in Malaysia
3.1 Introduction
Cancer has been reported as the third leading cause of death in Malaysia by the
Ministry of Health in Malaysia, after heart disease and pulmonary circulatory dis-
ease, and septicaemia. The five most common cancers in Malaysia in 2007, as re-
ported by the National Cancer Registry of Malaysia, were breast cancer, colorectal
cancer, lung cancer, nasopharyngeal cancer and cervical cancer at 18.1%, 12.3%,
10.2%, 5.2% and 4.6% of total cancers respectively (Omar and Ibrahim Tamin,
2011).Colorectal cancer is the second most common type of cancer for both sexes,




Cancer survival in Malaysia has been studied at a regional level. A retrospective
record review study analysed survival rates of patients diagnosed with colorec-
tal cancer between 1996 and 2005 in Hospital Universiti Sains Malaysia (HUSM),
Kelantan, (Ghazali et al., 2010). The study reported that the overall 5-year sur-
vival rate was 34.3% and three significant independent prognostic factors identified
were Dukes staging at diagnosis, the presence of liver metastases and treatment
modalities.
To date, there is no study looking into survival and prognostic factors for colorectal
cancer for the whole Malaysian population. In this chapter, we aim to identify the
effect of individual-level factors on survival prognosis for patients with colorectal
cancer in Malaysia.
3.2 Data
The original data that we received from the database of the NCPR-CC consisted
of 4501 patients with histologically verified primary colorectal cancer diagnosed
between 2008 and 2013 (ICD-10, C18-C20). After excluding patients without
Malaysian citizenship, patients with negative age and negative survival time, there
were 4412 subjects’ data available for analysis.
Variables chosen to be used to describe patients’ social demographic were age,
race, gender, education level and smoking status. The ‘age’ of the patients is
defined as the age when the patients were diagnosed with colorectal cancer, cal-
culated as the difference between the date of diagnosis and date of birth. ‘Race’
was recorded as Malay, Chinese, Indian, other Malaysian, foreigner, missing, or
unknown race. ‘Education level’ was based on the patient’s highest grade/edu-
cation level completed or achieved; this is recorded as ‘nil’ if the patient did not
receive any formal education. Primary school consists of six years of education,
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referred to as Standard one to Standard six. Five years of Secondary school educa-
tion follow, for children aged 13 to 17. After Secondary school, tertiary education
can be undertaken. This includes pre-university, matriculation and other higher
levels of education, and can be at public or private institutions of higher learning.
‘Smoking status’ indicates if the patient had a confirmed history of usage of any
form of tobacco. This includes cigarette, cigar and pipe smoking, and tobacco
chewing. They are categorized as ‘Never’ or ‘Non-smoker’, ‘Former smoker’ (quit
> 30 days), ‘current smoker’, ‘unknown’, or ‘missing’.
For clinical characteristics, the presence of diabetes mellitus, tumour site, stage at
diagnosis, the presence of metastases, and tumour differentiation were chosen to
be included in the study. Presence of diabetes mellitus was recorded as ‘No’, ‘Yes’,
‘unknown’, or ‘missing’. ‘Tumour site’ describes the site of the primary tumour
at diagnosis, and is categorised according to ICD-10 classifications as either at
the colon, the rectosigmoid junction or the rectum. These, along with ‘missing’,
comprise the variable levels used in this data set. Stage of cancer is based on final
TNM Staging, recorded in the data as Stage I, II, IIA, IIB, IIIA, IIIB, IV, ‘not
staged’, ‘missing’, ‘not available’ or as the missing value NA. The categorisation
of ‘tumour differentiation’ is based on the proportion of the tumour that is gland
forming. If the tumour is > 95% gland forming, it is recorded as well differentiated;
50-95% gland forming as moderately differentiated, and < 50% gland forming as
poorly differentiated. In the data given to us, tumour differentiation was recorded
as ‘well differentiated’, ‘moderately differentiated’, ‘poorly differentiated’, ‘not ap-
plicable’, ‘missing’ and ‘NA’. Distant metastases were reported either by surgical
or histopathological report and have been separated into each possible metastatic
site. Data on each site of metastasis is recorded as ‘No’, ‘Yes’ and ‘NA’.
The ‘treatment modalities’ variables record seven different types of treatment re-
ceived by patients, namely: no therapy, radiotherapy, chemotherapy and biological
therapy, supportive care/palliative care, endoscopy, complementary/alternative
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treatment and unknown. Each of these was recorded as either ‘TRUE’ or ‘FALSE’
for the stated treatment.
Patient status in this data is given as either dead, alive, or lost to follow up. The
date and cause of death were documented in our data where applicable. For each
patients, survival time was computed from the date of diagnosis to date of death
and follow up was done to the end of 2013 or the censoring date in this study was
31st of December 2013.
3.2.1 Modification of the Data Categories
There are many instances in this dataset of information being missing or incom-
plete, but these are recorded inconsistently with a variety of indicators such as
‘missing’, ‘not applicable’, ‘not available’, ‘unknown’ or ‘NA’. These do not always
match up with the categories defined for each variable in the data. We therefore
decided to combine these various missing data as ‘unknown’ or ‘not applicable’
if these categories were stated as such in the patients’ form, or just as ‘missing’
otherwise. We also obtained advice from our data provider about the ‘uncertain’
category recorded in the database to justify our decision in data categorization.
For example, even though the variable ‘tumour differentiation’ has categories of
‘not applicable’, ‘not available’ and ‘missing’, most of the data in these categories
did not tally with the data definition. Our data provider clarified this, and assured
us that all data in those categories of this variable were actually just ‘missing’.
In consideration of the social demographic variables, we firstly recategorised race
as Malay and non-Malay because of the small number of patients in each race that
was non-Malay. Smoking status was categorised to: non-smoker, former smoker,
active smoker and missing status. Education level was classified as ‘Nil’, ‘Primary’,
‘Secondary’, ‘Tertiary’ and ‘missing’ group.
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With regard to the clinical characteristics, diabetes status was simplified to the
three categories: yes, no and missing. ‘Cancer site’ was unchanged, but ‘stage
of cancer’ was recategorized to ‘Stage I’, ‘StageII’, ‘StageIII’, ‘Not staged’, and
‘missing’. Since the ‘site of distant metastases’ contains many categories, each
of which only contains a small number of data points, we decided to combine all
the metastases regardless of their specific site. Irrespective of where and when
it has been detected, the ‘presence of distant metastases’ was therefore reclassi-
fied into ‘yes’, ‘no’ and ‘missing’. ‘Tumour differentiation’ was recorded as ‘well’,
‘moderate’, ‘poor’ and ‘missing’.
The treatment modalities were categorized into four types of treatment received
by the patients. They are patients who underwent surgery alone, patients who
underwent surgery followed by chemotherapy and/or radiotherapy, patients who
underwent chemotherapy and/or radiotherapy and patients who got other alter-
native treatments or palliative care. Patients without information of treatment
received were recorded as an unknown group.
The specific cause of death provided in the data was not verified and could not
therefore be deemed reliable, so we decided to perform the analysis on all-cause
mortality. The data records whether each patient is dead or alive at the end of
the study period; we relabel each patient’s status as either dead or censored. The
censored group are patients who were alive until the end of the study period as
recorded in the database.
3.2.2 About Missing Data
There are a total of 4412 patients in this study and only 742 patients have complete
data for all chosen covariates. The reason behind the degree of missing data is
likely that data collection and data entry procedures are not standardised across all
hospital sites. Patient information was gathered either from the physician directly
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or by Registry staff reading through the patients’ notes, it is written onto a patient
form and then entered into the database by the cancer registry staff. There is a
possibility of third party error in the database. Because of these irregularities,
we feel the combination of the various missing data categories described in the
previous section to be justified.
We compare the overall survival using Kaplan Meier survival curves for data with
all observations (4412) and the data with complete cases only (742 observations).
The overall survival probability in all data was significantly lower compared to
those with the complete covariate data (Figure 3.3). We also investigated how
the risk of death increased with more missing covariates, and we acknowledge
that there is a possibility of introducing bias if we ignore or exclude the cases
with missing data (Figure 3.2). Thus, we decided to keep the missing data in
this study as a ‘missing’ group, choosing to analyze separately the full data set
(allowing ‘missing’ as one of the categories) and the data with complete cases.
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Figure 3.1: Kaplan Meier plot comparing survival probability for all data vs
complete covariate data
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Figure 3.2: The hazard of death increases with increasing ‘missing’ covariates
3.3 Survival Probabilities
The probability of surviving until a particular time is presented in a plot of survival
curves, calculated using the Kaplan Meier estimator (Kaplan and Meier, 1958),
also known as the product limit estimator, which can be calculated by most com-
mon statistical software packages. The estimator incorporates information from
all of the observations available, both uncensored and censored, by considering sur-
vival to any point in time as a series of steps determined by the observed survival










where nj is the number of individuals at risk, dj is the number of deaths in the time
interval from t(k) to t(k+1), with k= 1, 2, 3,. . . r events occurring at times t1 ≤ t <
t2 ≤. . .≤tr. The Kaplan Meier estimate of the survivor function is a step function,
in which the estimated survival probabilities are constant between adjacent death
times (regardless of further censored events occurring) and decrease at each death
time.
We also calculated the overall 5-year survival rate and the overall median survival
rate for colorectal cancer patients in our study. The survival rate is the percentage
of people in a study who are still alive for a certain period of time after they
have been diagnosed with the disease. In this study, the 5-year survival rate for
colorectal cancer is defined as the percentage of patients with colorectal cancer
who are still alive five years after diagnosis. The median survival time is the first
observed time at which cumulative survival was 50% or less; that is, the time when
half of the patients have died.
3.4 Statistical Model
3.4.1 Fitting a Cox Proportional Hazard Regression Model
A Cox regression model was used to explore the relationship between patients’
survival and the chosen explanatory variables (Cox, 1972) . The Cox model is
written as
hi(t) = exp (β1x1i + β2x2i + · · ·+ βpxpi)h0(t)
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hi(t) = h0(t) exp{Xiβ}
hi(t) gives the value of the hazard function for the i
th individual at a particular
time t. Here Xi is a vector of explanatory variables for individual i, β is a vector
of regression coefficients to be estimated and h0 is the baseline hazard function,
which is left unspecified (though it can be estimated after the model has been
fitted). The baseline hazard tells us how the rate of events changes over time:
whether it increases, decreases or remains constant. Analysis was performed using
the survival package in R (Therneau, 2015).
The reader will note that we have chosen not to undertake variable selection in
the development of our models. The main reason for this is that we are not
seeking to identify new predictors of survival in our study, rather we are seeking
to evaluate the role of established predictors of survival and adjust those estimates
to account for the other well-known confounding factors. While the present study
is not sufficiently powered to be able to detect statistically significant effects of all
variables at the 5% level, going forward in time, as cancer registries collect more
data, and more complete data, it will be important to include each of these known
predictors. At some point in the future, it would will be appropriate to undertake
a study that seeks to identify which are the important variables in this context.
Our opinion is that it is too early, at present, to undertake such a study.
3.4.2 Model Diagnostics
The validity of the proportional hazards (PH) assumption can be assessed using
Scaled Schoenfeld residuals. We used the cox.zph function from the survival
package in R (Therneau, 2015). We tested the PH assumptions on each of the
covariates in the model and for the overall model, which is the global test (Fox
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and Weisberg, 2011). The null hypothesis is that the (scaled) Schoenfeld residuals
are independent of failure times or equivalently that the hazard is constant over
time. This implies that the Schoenfeld residuals are uncorrelated with time. A
p-value was computed for each covariate, along with a global test for the model
as a whole.
We also fitted the Bayesian Cox time-varying coefficient model using the R package
dynsurv to check if a model with time-varying coefficients is more appropriate.
This package has a function bayesCox which is used to fit the time-varying coef-
ficient model (Wang et al., 2017):
hi(t) = ho(t) exp{Xiβ(t)}
i.e the regression coefficients are allowed to vary with time. We looked at the
result using a range of priors and produce the plot for each variable. We produced
plots of β(t) against t to check for time-varying effects.
We checked the fit of the model and identified influential observations by perform-
ing diagnostic checks on the standardised residuals. Martingale residuals were used
to determine the correct functional form of continuous covariates; a straight line
plot indicates that a linear term is needed. The df-beta residual plot was used to
identify influential observations. Each of the potential extreme observations was
assessed for its influence by considering the percentage change in the variable’s
coefficient (∆βˆ%) when the model is refitted without this observation. The clin-
ical plausibility of the observation was also considered in assessing the influential
cases (Hosmer and Lemeshow, 1999).
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Cox Snell residuals were used for assessing overall model fit and determining
whether the Cox regression model is a suitable choice for this data. A straight
line with a unit slope and zero intercept indicates that the fitted survival model




3.5.1.1 Summary Statistics - A Profile of Colorectal Cancer Patients
in Malaysia
The number of colorectal cancer cases reported in the Registry increased by around
34%, from 639 in 2008 to 964 in 2009/10. The cases started to decrease in 2010 to
only 363 cases in 2013. There were 1979 (45%) deaths from all cases in the 6 year
period, while the remaining 2433 (55%) were alive and institutionally censored
(Table 3.1).
Table 3.1: Colorectal Cancer Cases by Year
Year Number of cases Died, n (%) Censored, n (%)
2008 639 377 (59) 262 (41)
2009 964 517 (54) 447 (46)
2010 964 473 (49) 491 (51)
2011 734 313 (43) 421 (57)
2012 748 248 (33) 500 (67)
2013 363 51 (14) 312 (86)
Total 4412 1979 (45) 2433 (55)
Patients’ ages ranged from 9 to 98 years old with mean 61.2 years and standard
deviation 12.7. 55% of the patients were male and there were more male deaths.
Table 3.2 illustrates the socio-demographic profile of colorectal cancer patients in
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this study. 43.1% patients were of the Malay race, 56.4% were non-Malays and
22% had missing ethnicity. In the six-year duration of the study, 10% were active
smokers, 12% are former smokers and 35% were non-smokers. 59% of patients in
the data had no information on their level of education (Table 3.2).
22% of the colorectal cancer patients were recorded in the registry as having di-
abetes mellitus. The commonest tumour site, according to ICD-10, was in the
colon, followed by the rectum and the rectosigmoid junction. Among patients for
whom cancer stage was recorded, the majority were diagnosed at Stage III, ac-
cording to their final TNM staging. With regards to tumour differentiation, 57%
of patients were classified as having a moderately differentiated tumour.
Surgery is the most common treatment for colorectal cancer. The majority of
patients (70.4%) had surgery as their primary treatment. Some of them had
chemotherapy or radiotherapy or both in addition to surgery. A small number
of patients (3.0%) had other treatments which include alternative treatment or
palliative care (Table 3.3).
There were a lot of missing data in our study. The highest proportion of missing
data was seen in the ‘Education Level’ variable (59.2%), though smoking status
and cancer stage also had 43.4% and 34.6% missing respectively.
3.5.1.2 Survival Probabilities and Kaplan Meier Survival Curves
The Kaplan Meier estimates for all data are shown in Figure 3.3. The overall
survival rate at the end of the first year was almost 80%, and the overall survival
rate for the entire 5-year period in this study was 44%, 95% CI (42%,46%).
Kaplan Meier survival curves show that female patients had better overall survival
compared to males but the difference was not statistically significant. People of
the Malay race show significantly lower survival compared to those of non-Malay
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Table 3.2: Profile of colorectal cancer patients - socio-demographic character-
istics
Variables Number of patients, (%) Died, n (%) Censored, n (%)
Total(N) 4412 (100) 1979 (49) 2433 (55)
Sex
Female 1894 (42.9) 824 (41.6) 1070 (44.0)
Male 2470 (56.0) 1142 (57.7) 1328 (54.6)
Missing 48 ( 1.1) 13 ( 0.7) 35 ( 1.4)
Total 4412 (100) 1979 (100) 2433 (100)
Race
Non Malays 2489 (56.4) 1043 (52.7) 1446 (59.4)
Malays 1901 (43.1) 929 (46.9) 972 (40.0)
Missing 22 ( 0.5) 7 ( 0.4) 15 ( 0.6)
Total 4412 (100) 1979 (100) 2433 (100)
Smoking status
Non smoking 1543 (35.0) 643 (32.5) 900 (37.0)
Former smoker 528 (12.0) 248 (12.5) 280 (11.5)
Active smoker 423 ( 9.6) 214 (10.8) 209 ( 8.6)
Missing 1918 (43.4) 874 (44.2) 1044 (42.9)
Total 4412 (100) 1979 (100) 2433 (100)
Education
Nil 399 ( 9.0) 201 (10.2) 198 ( 8.1)
Primary 553 (12.6) 247 (12.5) 306 (12.6)
Secondary 651 (14.8) 271 (13.7) 380 (15.6)
Tertiary 195 ( 4.4) 60 ( 3.0) 135 ( 5.6)
Missing 2614 (59.2) 1200 (60.6) 1414 (58.1)
Total 4412 (100) 1979 (100) 2433 (100)
origin. The tertiary education group showed significantly better overall survival
compared to other education groups and survival rates got progressively worse for
lower education groups. Non-smokers showed higher overall survival than all other
smoking status groups (Figure 3.4).
The Kaplan Meier plot illustrates that colon cancer patients had better overall
survival compared to patients in the other groups. The overall survival of rectal
cancer and rectosigmoid cancer were very similar for the first two years after
diagnosis, though rectal cancer had a marginally better long term prognosis. The
overall survival rate for rectosigmoid cancer was better than that for rectal cancer
beyond two years after diagnosis.
The overall survival for those with moderately differentiated tumours was signifi-
cantly better compared to poorly differentiated tumours and the ‘not applicable’
group. The overall survival was also significantly different for varying stages of
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Table 3.3: Profile of colorectal cancer patients - clinical characteristics
Variables Number of patients, (%) Died, n (%) Censored, n (%)
Total(N) 4412 (100) 1979 (49) 2433 (55)
Diabetes
No 3021 (68.4) 1349 (68.2) 1672 (68.7)
Yes 982 (22.3) 449(22.7) 533 (21.9)
Missing 409 ( 9.3) 181 ( 9.1) 228 ( 9.4)
Total 4412 (100) 1979 (100) 2433 (100)
Cancer site
Colon 2394 (54.3) 981 (49.6) 1413 (58.1)
Rectosigmoid 631 (14.3) 305 (15.4) 326 (13.4)
Rectum 1379 (31.2) 692 (34.9) 687 (28.2)
Missing 8 ( 0.2) 1 ( 0.1) 7 ( 0.3)
Total 4412 (100) 1979 (100) 2433 (100)
Staging
Stage I 215 ( 4.9) 34 ( 1.7) 181 ( 7.4)
Stage II 600 (13.6) 141 ( 7.1) 459 (18.9)
Stage III 802 (18.2) 320 (16.2) 482 (19.8)
Stage IV 647 (14.7) 455 (23.0) 192 ( 7.9)
Not staged 620 (14.0) 213 (10.8) 407 (16.7)
Missing 1528 (34.6) 816 (41.2) 712 (29.3)
Total 4412 (100) 1979 (100) 2433 (100)
Tumour Grade
Well 358 ( 8.1) 129 ( 6.5) 229 ( 9.4)
Moderate 2497 (56.7) 986 (49.8) 1511 (62.1)
Poor 161 ( 3.6) 96 ( 4.9) 65 ( 2.7)
Missing 1396 (31.6) 768 (38.8) 628 (25.8)
Total 4412 (100) 1979 (100) 2433 (100)
Distant Metastases
No 1922 (43.6) 630 (31.8) 1292 (53.1)
Yes 1521 (34.4) 771 (39.0) 750 (30.8)
Missing 969(22.0) 578(29.2) 391(16.1 )
Total 4412 (100) 1979 (100) 2433 (100)
Treatment modalities
Surgery Alone 1658 (37.6) 659 (33.3) 999 (41.1)
Surgery Chemo Radio 1454 (32.9) 604 (30.5) 850 (34.9)
Chemo Radio 437 (9.9) 233 (11.8) 204 ( 8.4)
Other treatments 140 ( 3.2) 100 ( 5.0) 40 ( 1.6)
Unknown 723 (16.4) 383 (19.4) 340 (14.0)
Total 4412 (100) 1979 (100) 2433 (100)
cancer at diagnosis, with the poorest survival seen in Stage IV and the highest
survival in Stage I. The overall survival for ‘unknown’ stage was inbetween the sur-
vival rates for Stage III and Stage IV. The overall survival in the group displaying
no metastases was significantly better than the group known to have metastases
present, but the ‘unknown’ group had the lowest overall survival of the three.
Survival was not significantly affected by the presence of diabetes. Consider-
ing treatment modalities, the overall survival rates among patients who received
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surgery with adjuvant therapies (chemotherapy or/and radiotherapy) were higher
than those of the ‘surgery alone’ group in the first two years after diagnosis; though
the surgery alone group had better overall survival thereafter. The overall survival
of those who had radio/and chemotherapy alone was not much different from the
‘unknown’ treatment group. The lowest survival was seen in the ‘others’ treatment
group (Figure 3.5).























Figure 3.3: Kaplan Meier curve shows the overall survivor function for col-
orectal cancer cases in the study
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Figure 3.4: Kaplan Meier survival curves for sex, race, smoking and education
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Figure 3.5: Kaplan Meier survival curves for cancer site, tumour grade, stage
of cancer, presence of distant metastases, diabetes and treatment modalities
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3.5.2 Cox Regression Model: Deducing The Effect of Individual-
Level Factors on Colorectal Cancer Survival
We fitted a Cox regression model to each of two sets of data: one set containing
all data (4412 cases) and one comprising only those with complete covariate in-
formation (742 cases). Age, third-degree education, cancer staging, poor tumour
differentiation, the presence of distant metastases and receiving ‘other’ treatments
were factors that increased the risk of death for colorectal cancer patients in both
models.
Our model shows that the most important prognostic factor affecting survival in
colorectal cancer patients is the stage at diagnosis. Patients diagnosed when their
cancer was already at Stage IV had an almost 6-fold greater risk of dying from
colorectal cancer than those who were diagnosed at Stage I.
Patients who were active smokers had a greater risk of dying compared to non-
smokers in both models but the effect was not significant in the model with all data.
Malay race and tumour at the recto-sigmoid junction increased significantly the
risk of dying in the model with all patients. Diabetic patients had a significantly
greater risk of dying compared to non-diabetic patients in the model with complete
covariate data, but this effect was not significant in the all-case data set.
Overall, the factors that affect the survival of patients with colorectal cancer were
not greatly different in each model. So, we decided to choose the model with
all-case data as our final model. Table 3.4 presents the effects of covariates on
colorectal cancer survival, given in terms of hazard ratios.
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Table 3.4: Cox Regression Model for complete covariate data and all data
No. cases (N=4412) All cases Complete cases
Variable HR, (95% CI) HR, (95% CI)
Age 1.01 (1.01, 1.02 ) 1.01 (1.00, 1.02)
Sex
Female 1894 1 1
Male 2470 1.01 (0.91, 1.11) 1.08 (0.79, 1.46)
Missing 48 0.67 (0.38, 1.18)
Race
Non Malay 2489 1 1
Malay 1901 1.32 (1.21, 1.45) 1.22 (0.95, 1.58)
Missing 22 1.38 (0.64, 2.97)
Smoking
Non-smoking 1543 1 1
Former Smoker 528 1.25 (1.07, 1.47) 1.02 (0.72, 1.46)
Active smoker 423 1.17 (0.99, 1.39) 1.70 (1.16, 2.50)
Missing 1918 1.04 (0.93, 1.18)
Education
No Education 399 1 1
Primary 553 0.92 (0.76, 1.12) 0.85 (0.58, 1.23)
Secondary 651 0.96 (0.79, 1.16) 0.97 (0.66, 1.43)
Tertiary 195 0.60 (0.45, 0.81) 0.56 (0.32, 0.98)
Missing 2614 1.01 (0.87, 1.19)
Diabetes
No 3021 1 1
Yes 982 1.07 (0.96, 1.20) 1.43 (1.06, 1.92)
Missing 409 0.85 (0.72, 1.00)
Cancer site
Colon 2394 1 1
Rectosigmoid junction 631 1.16 (1.02, 1.32) 0.87 (0.60, 1.28)
Rectum 1379 1.08 (0.97, 1.19) 0.88 (0.66, 1.17)
Missing 8 0.24 (0.03, 1.72)
Staging
Stage I 215 1 1
Stage II 600 1.53 (1.05, 2.24) 1.68 (0.81, 3.47)
Stage III 802 2.86 (2.00, 4.08) 3.72 (1.86, 7.45)
Stage IV 647 5.59 (3.90, 8.00) 6.02 (2.85, 12.70)
Not staged 620 2.66 (1.85, 3.84) 3.98 (1.85, 8.57)
Missing 1528 3.54 (2.50, 5.02)
Tumour Differentiation
Well 358 1 1
Moderate 2497 1.19 (0.99, 1.43) 0.90 (0.59, 1.36)
Poor 161 2.32 (1.78, 3.03) 1.41 (0.78, 2.53)
Missing 1396 1.58 (1.30, 1.92)
Distant Metastases
No 1922 1
Yes 1521 1.46 (1.29, 1.65) 1.44 (1.02, 2.01)
Missing 969 1.51 (1.29, 1.77)
Treatment Modalities
Surgery Alone 1658 1 1
Surg, Chemo, Radio 1454 0.90 (0.80, 1.01) 0.79 (0.60, 1.03)
Radio, Chemo 437 1.14 (0.96, 1.35) 1.41 (0.89, 2.23)
Others 140 1.85 (1.47, 2.32) 2.79 (1.01, 7.73)
Unknown 723 1.17 (1.00, 1.36)
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3.5.2.1 Checking collinearity
In our analyses, if some of the independent variables were highly correlated, then
the problem of multicollinearity could arise. These are a concern in data analyses
because it means that at one predictor variable can be used to predict another -
this creates redundant information in the model.
Since all of our variables are categorical (except for age), and computing correlation
of such variables is not ideal, we looked at the correlation between the estimated
parameters of the model instead. Our results shows no collinearity problem in our
variables/predictors in the model. We additionally used the Variation inflation
factor to check for multicollinearity. If the VIF for each variable in the model
was less than 10, this indicates that there was no multicollinearity problem in the
model. If the VIF was more than 10, this means that there is a multicollinear-
ity problem and the variable should be excluded from the model. The variables
demonstrated Variance Inflation Factor (VIF) of less than 10 which indicated no
multicollinearity problem among those variables
3.5.2.2 Checking for Interactions
The possibleinteraction between variables in the model were checked by fitting
cross product terms. The interactions were checked between the variables smok-
ing,education, treatment, staging, site, tumor diffrentiation and metastasis.No in-
teraction was found to significantly improve model fit
3.5.2.3 Diagnostic Test: Checking the Proportional Hazards Assump-
tion
The test statistics based on the Schoenfeld residuals indicate that there is a statis-
tically significant trend with time in the residuals for five of our variables (Staging,
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Treatment, Race, Grading and ICD Site). A global test of residuals for the whole
model was also found to be highly significant (p < 0.001); this indicates that the
discrepancy between predicted and observed covariate value does vary with time
and that the proportional hazards assumption may not hold.
The plot in R translates the residuals by adding βˆ, so that covariates without time-
trend should form a smooth line close to the fixed estimate of β along the whole
time range. The Schoenfeld residual plots (Figure 3.6) suggest some departure
from the proportional hazard assumption, but the trend is not consistent. The
apparent initial positive slope for some variables maybe overly influenced by one
or two large negative residuals.
We therefore fitted a dynamic survival model, detailed on page 62, using the
dynsurv package. We produced plots of β(t) against t (Figure 3.7) and these
showed no evidence that the coefficients of variables in the model do vary over
time. The confidence intervals and the effect size remain roughly constant over
time.
We experimented with a range of different priors for the time-varying coefficient
model, created using bayesCox in the dynsurv package, and the results do not
show any trends with time. Residual plots for these time-dependent models (Fig-
ure 3.7) show no evidence that the coefficients of variables in the model do vary
over time. Therefore, even though the Schoenfeld residuals initially suggest some
departure from the PH assumption, it was not considered necessary to introduce
time-varying covariates to the model, as evidenced by the plots from the dynamic
survival model. Therefore, we decided that use of the Cox proportional hazard
















































































































































Figure 3.6: Scaled Schoenfeld residual plot
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Stage2 Stage3 Stage4 Stageunknown GradeModerate GradePoor
GradeMissing age met2Yes met2missing ICDSiteRectum ICDSiteRectosigmoid junction
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Figure 3.7: Plots of residuals derived from the time-varying coefficient model
The Cox-Snell residuals showed that our final Cox regression model fits the data
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very well. This was shown by the plot of cumulative hazard versus Cox-Snell
residual which produced an almost straight line with a unit slope and zero intercept
as shown in Figure 3.8.

























Figure 3.8: Cox-Snell Residual for assesing model fitness
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3.6 Discussion
This study is a preliminary investigation of the factors that will influence the sur-
vival of patients who have been diagnosed with colorectal cancer. The data we
have used come from the Malaysian National Cancer Patient Registry for Col-
orectal Cancer (NCPR-CC), which sources the data from 34 reference centres for
colorectal cancer across Malaysia. Our analysis is based on data from 6 years of
diagnoses and contains records on 4412 people, who are all Malaysian citizens.
An alternative approach that we could be applied to our data is the net survival
method (Perme et al., 2012). In estimating net survival, there are approaches
that can be applied: the cause specific approach and the all-cause mortality ap-
proach. The first requires knowing the cause of death for each individual and the
second one requires all-cause mortality in the study group and an estimate of the
“expected” mortality of a disease-free group having the same demographic charac-
teristics as the study group. In a situation where the cause of death is not known,
net survival estimators assume that the available expected cancer mortality rate
correctly reflects mortality rates from other causes . This can be obtained from
general population life tables. The mortality due to cancer can then be deduced
from the all-cause and other-cause mortalities. This is also known as the excess
hazard, if it refers to hazard.
Epidemiological studies usually use the second of the above approaches because
cause of death is often unavailable or unreliable. Cancer epidemiologists use
“Relative-survival methods” for net survival estimation when there is no infor-
mation on the cause of death (Roche et al., 2013). The net survival method is
applicable to measure cancer survival after excluding the influence of other causes
of death and is very useful in large scale studies such as EUROCARE-4 (Euro-
pean cancer registry based study on survival and care of cancer patients) and
iCONCORD (Global surveillance of cancer survival study) (Coleman et al., 2008,
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Sant et al., 2009) where population survival differs substantially between countries
(Perme et al., 2012).
We may consider using this method in future research with access to more data in
order to get better picture of survival comparisons between countries, for instance
extending our study to South East Asian countries. However, in this thesis we
chose to use the more widely applied Cox model; one advantage of doing this is
that there already exists software for handling our planned work in spatial survival
data analysis, though the extension to spatial net survival models would be novel
and useful to the research community.
Older age, having Malay ethnicity, higher cancer staging, the presence of dis-
tant metastases, having a poorly differentiated tumour, having ‘other’ treatment
modalities and having ever smoked were all associated with statistically significant
increases in risk of death in patients with colorectal cancer, while higher education
level statistically decreased the risk of dying from colorectal cancer.
We found that cancer staging was the main factor affecting the risk of death
in patients diagnosed with colorectal cancer. This data shows that there was
an almost six-fold increase in the risk of death in patients with stage IV cancer
compared to those with stage I cancer. This is consistent with previous findings
(Kotake et al., 2016, Maringe et al., 2013, McKay et al., 2014) and is obviously
supported by biological theory because the stage of cancer describes the extent
and severity of the disease at the commencement of treatment.
Many studies have reported that age was an independent prognostic factor for
colorectal cancer (McKay et al., 2014, Stornes et al., 2014, Widdison et al., 2011).
Fu et al. (2014) noted that the youngest age group in their study (≤35 years old)
had significantly poorer overall survival rate compared to older patients due to
the greater proportion of these younger patients presenting at a late stage of can-
cer. However, having accounted for other variables, age was not an independent
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prognostic factor in their study. Previous research analyzed age as a categorical
variable, while our study analyzed age as a continuous variable. The data sup-
ported a linear trend in log risk with age. Our findings show that there is a very
slight increase in the risk of death for each extra year of age at diagnosis.
Malaysia is a multi-ethnic country; the three main ethnic groups in Malaysia are
Malay, Chinese and Indian. The predominant ethnic group in Malaysia is Malay,
constituting 63.1% of the total population in Peninsular Malaysia. Hassan et al.
(2016) reported that the Chinese ethnicity has the highest age adjusted mortality
rate (11.85 deaths per 100,000 population), compared to 9.56 and 7.08 deaths per
100,000 population in Malay and Indian races respectively. However, they did
not assess the risk of death from colorectal cancer for each of these ethnic groups
separately. In our study, we have re-categorized race into Malay and Non-Malay
to compare their risk of death from colorectal cancer. There are fewer Malay
patients than non-Malay in this dataset (43% vs 56.4%), and we find that Malays
had shorter survival than non-Malays; they had a 30% greater risk of dying from
colorectal cancer than the non-Malays in our study.
Different populations may have different types and levels of education and little is
hitherto known about how patient education level may affect survival of colorectal
cancer. Cavalli-Bjo¨rkman et al. (2011) grouped their patients into three levels
of education: low, middle and high education, and found that both middle and
high education had significantly lower risk of death compared to the low education
group. They assume that the low education group had received less treatment and
different types of surgery than others in the two higher educational categories.
For our data, we found that patients with a tertiary-level education had a 40%
lower risk of death than those without any formal education. Education level is
often associated with socioeconomic status and those with higher socioeconomic
status commonly demonstrate better survival than those who do not. One study
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has suggested that higher survival rate can be achieved if the colorectal cancer
patients adopted w ere to adopt a healthy lifestyle, and had better accessibility to
medical care and higher level education (Rasouli et al., 2017).
In the meantime, public health information could be disseminated widely to help
the population better what signs to look for and when to visit the doctor should
early signs of cancer manifest themselves. Information on of available screening of
screening programs should be made widely available to the population to encourage
attendance.
Smoking has been reported to lead to poorer survival in colorectal cancer pa-
tients.Walter et al. (2014), Phipps et al. (2013) and (Boyle et al., 2013) all sup-
port the finding that smoking adversely affected all-cause mortality in colorectal
cancer patients. A possible mechanism by which smoking impacts colon cancer
survival is related in some way, to surgery. A recent study found that colon cancer
patients who were current smokers who received surgery alone had a significantly
higher risk of death (Adjusted HR = 1.14, 95% CI: 1.07;1.12) from colon cancer
compared to those in the never smoker group (Sharp et al., 2017).
It is reasonable to expect an effect of cancer incidence from smoking, but there is
also evidence that smoking affects survival from colorectal cancer (Phipps et al.,
2011).The association between current smoker and survival of colorectal cancer in
our study was slightly insignificant but we did see a significant association between
smoking and reduced survival in the former smoker group. Former smokers had
a statistically significant 25% increase in the risk of dying from colorectal cancer
compared to non-smokers. The risk for former smokers is higher even than for
active smokers, who have a 17% increased risk of death compared to non-smokers.
This could be because the classification of former smoker in this study is quite
short (quit > 30 days). We did not take into account the length of time for which
ex-smokers had not smoked, or the number of cigarettes smoked per day. The
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effect of smoking may still be present if the former smokers had smoked for long
periods of time, for example, more than 10 years. A previous study (Chao et al.,
2000) on cigarette smoking and cancer mortality reported that there is a significant
relationship between duration of smoking with mortality from colorectal cancer.
Moreover, the risk of deaths among former smokers decreases with the number of
years since they have stopped smoking.
Furthermore, in our study, cases’s smoking status was derived by from medical
records, and was not routinely recorded therein. Consequently assessement and
assigning of exposure to smoking may be subject to misclassification, as we noted
earlier that smoking also was found as the variable with the highest missing value
in our data. Therefore, any association of between current smoker and survival
from colorectal cancer in our study may not be picked up by our study. We
suggest registries make sure that this variable is routinely documented in cancer
registration form as it is an important variable to look for.
Cancer in the rectosigmoid junction and rectum are often grouped together as rec-
tal cancer or as left-sided colorectal cancer, and the outcome from these alternative
classifications may be different to that which we observe here. Previous studies
have reported that cancer at the right-side (colon) has poorer outcomes than the
cancer at the left-side (combining recto-sigmoid and rectal cancers) (Price et al.,
2015). Our study classified the cancer sites separately as colon, rectosigmoid juc-
tion or rectum and we found that the cancer site was not a significant predictor
of outcome.
With regards to treatment modalities, our findings showed that the combination
of surgery and therapies (chemotherapy and/or radiotherapy) decreased the risk
of death compared to those who had surgery alone. This finding was similar to a
previous work on Malaysian colorectal cancer patients diagnosed in 2008-2009 by
Hassan et al. (2016). They suggested that their results were an indicator of the
Survival Analysis 82
importance of adjuvant therapies (chemotherapy or radiotherapy or both) after
surgery to prolong the patients’ survival from colorectal cancer. On the other
hand, patients with non-surgical treatments, such as chemotherapy, radiotherapy
or other alternative treatments, are reported to have a higher risk of death (Ghazali
et al., 2010, Yeole et al., 2001).
This study demonstrated a slightly increased risk of death in men, similar to the
findings of Lydrup and Ho¨glund (2015), but the result here was not statistically
significant. Cheung et al. (2013) stated a possibility that men may have a biolog-
ically more aggressive disease or a poorer response to adjuvant therapies, which
contributes to their poorer survival. On the other hand, Majek et al. (2013)
concluded that a better prognosis among women with colorectal cancer may be
explained by the use of postmenopausal hormonal replacement therapy (HRT).
Another previous study, Mandelson et al. (2003), suggested that HRT extended
survival in colon cancer.
Having diabetes mellitus, the known presence of distant metastases, and having
a poorly differentiated tumour were all found to be strong prognostic factors in
other studies (Aguero et al., 2012, Mills et al., 2013). In our study, the presence of
distant metastases and having a poorly differentiated tumour do have a significant
effect on the survival outcome for colorectal cancer patients, but having diabetes
mellitus does not. This contradictory result may be explained by the low number
of patients with this characteristic in our study compared to previous studies.
A particularly problematic aspect of our study was the large amount of missing
data. Much covariate data was unavailable; for instance, 59% of data in the
‘education level’ variable was missing. We noted that possible reasons for the data
being missing were non-standardised data collection and data entry procedures,
and the possibility of third party error in the recording of the data. We explored
the missing data cases and found that the risk of death increased with increasing
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number of missing covariates in our cases. As this might introduce bias into our
analysis, we decided not to ignore the cases with missing data; the missing values
were likely to be connected with clinically relevant factors such as cancer staging.
We assessed the likely effect on our results in two ways. First, we ran the analysis
including ‘missing’ as a level of each predictor variable. Secondly, we analysed
the subset of the study population for those who have complete data (n=742).
We compared the point estimate of the hazard ratio for both models. It was
reassuring to see that the results were very similar for both complete and all-case
datasets. We decided to choose all-data analysis as our main model as it is the
most appropriate dataset to use for the spatial analysis to be conducted in the
next chapter; this next analysis will involve the whole population and where they
live.
Despite this challenge, this remains the largest study of colorectal cancer survival
ever carried out in the country. With increasing rates of chronic disease in devel-
oping economies such as Malaysia, the results from this study are important and
will help in understanding the individual effects on colorectal cancer prognosis in
Malaysia.
We found that more than half of the patients presented late in the disease at Stage
III, Stage IV and missing stages. Our analysis revealed that the severity of the
disease lead to poor prognosis in colorectal cancer in the population after adjusting
for other individual characteristics such as age, gender and ethnicity. The five year
survival for patients with stage III cancer around 20%. In United States(US), the
equivalent figures are between 90 and 53% for Stage III and around 12% for Stage
IV (American Cancer Society, 2018). Cancer survival is affected by a number of
factors. Stage at diagnosis is one, and the success of the treatment regime another.
Age, race, smoking, and unemployment are others (Shi et al., 2013). To improve
survival in Malaysia one strategy would be to increase the percentage of cases who
present for diagnosis at StageI or II. The five year survival rate in US for colon
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cancer patients with stageI and II cancers are from 95 to 62%(American Cancer
Society, 2018).
The success of such a strategy would depend on a number of factors. Public health
campaigns can be helpful in persuading people with possible early signs of cancer,
such as blood in stool, to go to the doctor. For example the National Bowel
Cancer campaign in the UK has been successful in raising awareness, though they
recognise that a subsequent change in survival will take time to achieve (Cancer
Research UK, 2014).
In Malaysia, in contrast to UK, there are barriers to health care based on income
and social and economic circumstance. These too must be lessened or removed
so that money and physical availability of suitable healthcare does not prevent
people getting diagnosed and cared for when they have cancer.
Additionally, we think that health education programs targeting high risk group
and emphasizing the importance of early detection of cancer as well as knowledge
on the importance of cancer treatment should be implemented. Formulation of a
better screening program needs to be extended so that it is a genuinely national
program. Currently, Malaysia has no national screening for colorectal cancer.
More promotional activities with regards to cancer are recommended to increase
population survival rate in the future.
From the Kaplan Meier survival curve, we noted that in the non-education group
had the poorest survival. Their survival was similar to those in missing education
group, and it is possible that a bias has been introduced here since those with
education missing might be more likely to be of lower educational status. Even
though we found no interaction between cancer staging and education in this study,
it is likely that education plays an important role in survival from colorectal cancer.
Bringing awareness of public health issues to the population can be fitted by a gen-
eral improvement in education level across populations, so benefits would accrue
Survival Analysis 85
were the general population better informed about risks for poor health in middle
age. In the UK in 1999 general advice was given to the British population on
good lifelong health by the chief medical officer. One of the ten points was “take
up cancer screening opportunities”. Michael Marmot recognises that improving
knowledge does not improve behaviour, but actions to take up screening will help
identify cases sooner, which usually benefits survival (Marmot, 2015). Emphasis
needs to be given to the importance of early detection of colorectal cancer; both by
increasing public awareness among the Malaysian population and by the formula-
tion of a better screening program. This early detection would lead to diagnosis at
the earlier stages of cancer, which we have herein shown to best increase survival
rates in patients with colorectal cancer.
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Chapter 4
Colorectal Cancer in Malaysia: A
Spatial Survival Analysis
4.1 Introduction
A patient’s survival may depend on several known and unknown factors and it may
additionally vary spatially across a region. Socioeconomic status, accessibility to
healthcare and other environmental factors are likely to contribute to survival
rates.
Numerous studies have been carried out to investigate and model the spatial vari-
ation in survival for various types of cancer. For example, in north west England
Henderson et al. (2002) model the spatial variation in survival for leukaemia; Fair-
ley et al. (2008) assess the spatial variation in prostate cancer survival in England
and Hsieh et al. (2016) evaluate the factors affecting the spatial variation in breast
cancer survival in Queensland, Australia. Each of these studies report that spatial
variation in cancer survival exists.
91
Spatial Survival Analysis 92
Spatial variation in the survival of colorectal cancer specifically has been observed
in several studies conducted in developed countries. Henry et al. (2009) observed
disparities in survival across New Jersey among more than 25,000 people diagnosed
with colorectal cancer between 1996 and 2003. The lowest survival rates were
found mostly in economically deprived areas while those in aﬄuent areas had
longer survival times; the lack of healthcare accessibility is assumed to be one of
the key predictive factors here.
Baade et al. (2013) quantified the geographical variation in survival for colorectal
cancer patients using a discrete-time multilevel logistic survival analysis. Their
study, involving over 400 regions of Statistical Local Area (SLA) in Queensland,
Australia, demonstrated that patients in rural and disadvantaged areas had sig-
nificantly poorer survival rates than patients in urban and aﬄuent areas, after
controlling for individual characteristics and cancer stage.
In Spain, Etxeberria et al. (2014) mapped space-time patterns of colorectal cancer
mortality risk by sex and by two age groups - the middle-aged (50 to 69 years)
and the elderly (≥70 years) - during the period 1975 to 2008. Their findings
demonstrated spatial variation in mortality risk across the region by both sex and
age group.
Material deprivation and geographical accessibility to healthcare was found to
influence survival in colorectal cancer in a study involving the cases from three
cancer registries in France and one cancer registry in England (Dejardin et al.,
2014). This study showed that both of the above factors were relevant to patient
survival, but that the effect differs between the countries. Material deprivation was
significantly associated with cancer survival in England while lack of accessibility
to healthcare lead to poorer survival in France. The findings from these studies
suggest that it is important to investigate spatial variation in cancer survival in
Malaysia.
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Some previous studies have examined the spatial distribution of colorectal cancer
incidence in a subset of states in Malaysia but none have investigated the spatial
variation in survival of this disease (Samat and Shattar, 2014, Samat et al., 2013,
Shah et al., 2014). To our knowledge, no studies have examined the epidemiology of
this cancer using spatial modelling, and in particular none have extended research
to include the whole of Malaysia or the whole Malaysian population.
Our aim in this chapter is to model the spatial variation in survival for colorectal
cancer patients in Malaysia accounting for individual and socioeconomic risk fac-
tors. We also aim to investigate how individual and socioeconomic factors might
affect survival from colorectal cancer, adjusting for spatial location.
Identifying the factors that influence the difference in survival across the region
may help the public health authorities better plan healthcare delivery and thus
eventually reduce disparities in colorectal cancer survival in Malaysia.
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4.2 Methods
4.2.1 Data: Point Level Analysis
For three states in Peninsular Malaysia and one state in East Malaysia, we carried
out a spatial survival analysis based on individual location from addresses given
in the data. They were Kelantan, Kedah and Kuala Lumpur from Peninsular
Malaysia and Sarawak from the East Malaysia. We chose Kelantan and Kedah
because these states had a case ascertainment rate of greater than 95% as estimated
by our data provider, and Kuala Lumpur because it represents the capital state
of Malaysia for which it is estimated that over 90% of cases are recorded.
The population of the three states in Peninsular Malaysia (Kelantan, Kedah and
Kuala Lumpur) is about 4.6 million people (census 2010) while Sarawak, which
represents East Malaysia has 2,420,009 people in the same census year. Malays
represents the majority of the population in the three states in Peninsular Malaysia
which are Kelantan , Kedah and Kuala Lumpur with Malays being 94.6%, 77.6%
and 45% of the total population in Kedah, Perlis, Kelantan and Kuala Lumpur
respectively. Other races in the population include Chinese, Indian and other
races. In Sarawak, the state that represents East Malaysia in our study, Malays
represents 24.1% of the total population as Sarawak has their own indigenous
ethnicity(43.9%) known as Iban, Bidayuh and Melanau which are not part of the
population in Peninsular Malaysia (Department of Statistics Malaysia, 2016).
Addresses in Malaysia are assigned to a house, and will often, but not always,
contain a house name, a street name and a postcode. Unlike in the UK, a postcode
might contain all addresses in a small town. Often addresses are incomplete, with a
name and a village name only. In these circumstances we have derived coordinates
for the address based on the procedure outlined below.
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We created a data variable called ‘address’ to contain the coordinates for each
patients’ home address. The point coordinates had been determined from the ad-
dresses available in the database, though point coordinates were available for only
87%, 65%, 46% and 12% of the addresses in Kuala Lumpur, Kedah, Sarawak and
Kelantan respectively. For addresses where no address coordinate was available we
generated an approximate address at as fine a level as was possible. We started
with small street (a street of less than one kilometre length) and progressed to
housing area to village to ‘mukim’ (sub-division of the district) as necessary. An
average of 30% of the approximate coordinates were at the village level and 10% at
the mukim level while the rest are at a finer level (small street and housing area)
(Table ). We used Google Maps and 1MalaysiaMap (MaCGDI, 2012) to search
for the coordinates of the addresses. We ran our point-level analyses separately
for each state.
Table 4.1: Table of percentage(%) addresses assigns in the spatial analysis
model
States Accurate address(%) Small street Village(%) Small mukim(%) Total %
Kuala Lumpur 87 8 5 0 100
Kedah 65 10 19 6 100
Sarawak 46 8 38 8 100
Kelantan 12 8 55 25 100
4.2.2 Data: District Level Analysis
The district level analysis includes all districts in Peninsular and East Malaysia and
was based on polygonal data. However, the analysis for Peninsular Malaysia and
East Malaysia was done separately as they are substantially physically separated.
We therefore separated the shapefile of Malaysia into Peninsular Malaysia and
East Malaysia.
In order to conduct analysis at the district level, each patient was assigned to their
correct district based on their town variable as recorded in the data. Each of the
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520 unique names of towns seen in the data belong to one of the 144 administrative
districts in Malaysia, of which 87 districts are in Peninsular Malaysia and 57
districts in East Malaysia. Figure 4.1 shows the map of Malaysia by district.
We included a measure of socioeconomic index (Rahman and Zakaria, 2012) and
the intensity of hospitals as covariates in our model. The latter is a proxy for
access to healthcare facilities, the lack of which may delay patients seeking or
obtaining medical attention early on and hence decrease survival.
To model the correlation in space, we used an exponential correlation function,
using the distance between the centroids of regions to determine the correlation.
Figure 4.1: Malaysia by districts
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4.2.2.1 Accessibility to Healthcare
There are 165 hospitals in Peninsular Malaysia which include 90 public hospitals
and 75 private hospitals with in-patient care facilities. The hospitals in our data
do not include the National Heart Institute, the National Eye Institute or psychi-
atric hospitals. We obtained the coordinates of all these hospitals from Google
Maps. We create a proxy-measure for accessibility of healthcare using the esti-
mated number of hospitals per unit area (the intensity).
Let δ(x) denote a small region containing the point x. The intensity of hospitals








|δx| is the area of the small region
N (δx) is the number of points falling in δx
E[N (δx)] is the expected number of points falling in δx
The intensity of hospitals in each district was calculated using the density.ppp
function from the spatstat package in R. Then, we included this intensity as
one of the parameters in the spatial survival model. The intensity of hospitals
in Peninsular and East Malaysian districts respectively is presented in Figure 4.2
and Figure 4.3.
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Intensity of hospitals in districts
Figure 4.2: Intensity of hospitals in Peninsular Malaysia

























Intensity of hospitals in districts
Figure 4.3: Intensity of hospitals in East Malaysia
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4.2.2.2 Socioeconomic Status
We used an index based on information from a census in 2000 as a measure of
socioeconomic status in Peninsular Malaysia (Rahman and Zakaria, 2012). This
index refers to possession of certain items or attributes as follows:
• Percentage of households who own a car
• Percentage of households who own a motorcycle
• Percentage of households who have air-conditioning
• Percentage of households who own a video/dvd player
• Percentage of households with a tertiary education level (degree)
The index can have a positive or negative value. A more positive index for a
particular area indicates that the facilities in that area go beyond basic needs,
and vice versa for more negative indices (Rahman and Zakaria, 2012). This index
was available for 82 of the 87 districts in Peninsular Malaysia, and we used the
autoKrige function from the gstat R package to impute the value of the index
for the remaining five districts (Pebesma and Heuvelink, 2016). The autoKrige
function implements the technique of ordinary kriging, a method for smoothing
spatial data and predicting values for new locations (in this case, the centroids
of the districts with missing socioeconomic index). These are presented in Figure
4.4.
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socioeconomic index
Figure 4.4: SES index of districts in Peninsular Malaysia (census 2000)






































*The districts outlined in bold are those with imputed socioeconomic index value
4.2.3 Statistical Analysis
We create a parametric proportional hazards model using the spatsurv package
(Taylor and Rowlingson, 2017) to analyse our spatially referenced survival data.
The hazard function takes the following form:
h(ti;ψ, Yi) = h0(ti;ω) exp{Xiβ + Yi},
where
h0 is the baseline hazard function
t is the observed time for the ith individual
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Xi is a vector of covariate values for the i
th individual
ψ = (β, ω, η) are covariate effects, the parameter of the baseline hazard and the
parameter of the covariance function of a spatially latent Gaussian field Y , respec-
tively
Yi is the value of the field at the location of individual i
Our original data contained the addresses of the patients. We conducted two
different analysis on the data; point level analysis and district level analysis as
described previously.
We used MCMC to estimate the parameters in our model. We looked for evidence
of satisfactory convergence and mixing in the MCMC chain by considering the
mcmcplot of β, ω, η and Y . We compared plots of prior and posterior to check that
our data were sufficient to allow identifiability of the parameters in our model.
The model has been fitted using three different distributions for the baseline haz-
ards: Weibull, Exponential and B-spline. The models were compared using the
Watanabe-Akaike information criterion (waic) value.
We plot the posterior baseline and cumulative hazard for each model as well as
the spatial covariance function and correlation against distance. We also mapped
the probability that the covariate-adjusted relative risk exceeds certain thresholds.
These plots represent the risk over space that is not accounted for by the covariates
in our model.
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4.3 Results
Table 4.2 below shows the number of colorectal cancer cases and deaths in four
chosen states for the spatial survival model in this study.
Table 4.2: Colorectal cancer cases in four states chosen for spatial survival
model
States Cases(n) Death(n(%)) Alive(n(%))
Kedah 556 225(45.9) 301(54.1)
Kelantan 268 152(56.7) 116(43.3)
Kuala Lumpur 290 151(52.1) 139(47.9)
Sarawak(East Malaysia) 583 244(41.9) 339(58.1)
Total 1697 772(45.5) 925(54.5)
4.3.1 Point Level Analysis
4.3.1.1 MCMC Convergence from Trace Plots
We began by checking MCMC convergence by considering the trace plots for each
model for the four chosen states in the point analysis. The plots shown in Appendix
4.4 show that mixing is good and there is evidence for satisfactory convergence.
We next look at autocorrelation in the latent field, and then check the information
content in the data by plotting the priors against the posterior for each parameter.
The idea of these plots is that the data should move the prior somewhat; if the
prior and posterior are too similar, then there is little information in the data on
this particular parameter.
4.3.1.2 Model Comparison
We compared three possible models for the baseline hazard using WAIC; Table
4.3 shows these values. The model with the smallest WAIC value is considered
to have the best fit. In all four of the chosen states, the model using a Weibull
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Kelantan 2428.152 2434.033 2430.226
Kedah 4125.213 4145.084 4130.128
Kuala Lumpur 2472.562 2475.856 2473.387
Sarawak 4149.445 4153.215 4149.778
Table 4.3: Table comparing the WAIC values of models with Weibull, Expo-
nential and B-spline distributed baseline hazard functions, by state
Table 4.4 and Table 4.5 summarise the parameter effects described by the spatial
survival model for the four states chosen for the point level analysis. Age slightly
increased the risk of death for colorectal cancer and the association was signifi-
cantly found in Kedah and Sarawak states. Sex was not significantly associated
with the risk of death from colorectal cancer in any of the four states chosen in this
study. Being of Malay race was found to increase the risk of death from colorectal
cancer. We found that patients that had higher education level had a decrease in
the risk of death from colorectal cancer, in particular those with tertiary education
(degree) had the lowest risk of death from colorectal cancer. However, in Kedah,
we noted that those with secondary level education had more than twice the risk
of death than patients with no formal education.
Regarding smoking status, our evidence was mixed regarding the deviation of
the effect. In Kelantan, being a former smoker, active smoker or having missing
smoking status resulted in lower risk of death from colorectal cancer than the non
smoking group, but the effect was not significant. In contrast, in Kuala Lumpur
and Sarawak, former smokers and active smokers had more risk of death from
colorectal cancer compared to those who do not smoke. However, it was found to
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be significant in the smoker group for Sarawak only. Former smoker group and
missing smoking status positively affect the risk of death in Kedah but the effect
was not significant.
Colorectal cancer patients diagnosed with Stage IV cancer had the highest risk of
death from colorectal cancer in all states except Kuala Lumpur, where those at
Stage III at diagnosis had higher risk of death than Stage IV, but the effect was
not significant. The group with missing stage also had high risk of death in all
states but the effect was only significant in the state of Kedah.
The site of cancer did not significantly affect survival of colorectal cancer in any
of the states in our study. Tumours graded moderately or poorly differentiated,
or without a grading, were all at increased risk of death from colorectal cancer
compared to those graded as well differentiated. The presence of distant metastases
also had positive association with colorectal cancer survival even after controlling
for spatial correlation. However, the effect was only significant in Kuala Lumpur
and Kedah. Patients that underwent ‘other’ treatment had the lowest survival of
all treatment groups after accounting for correlation in space, but this was found
to be significant in Kuala Lumpur only. Diabetes mellitus was not significantly
associated with survival in colorectal cancer once adjusted for correlation on space.
Overall, when the spatial location is taken into account, cancer staging and tu-
mour differentiation play an important role in affecting survival in colorectal cancer
where the risk of death increased with higher cancer staging and poorer differentia-
tion of the tumour. On the other hand, high education level (tertiary) significantly
reduced the risk of death from colorectal cancer in these four selected states. Other
factors found to be significantly affecting the risk of death in certain states, after
controlling for spatial location, were the patient’s age, race, the presence of dis-
tance metastases and treatment modalities received by the patients. Patients’ sex,
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smoking status and diabetes status did not significantly affect the hazard of death
in colorectal cancer patients in all selected states in the model.
Table 4.4: Table of parameter estimates from the fitted model for four states in
Malaysia. Significant estimates (those whose credible interval does not contain
1) are given in bold font for ease of identification.
Kelantan(N=268) KLumpur(N=290) Kedah(N=556) Sarawak(N=588)
Variable Med (95% CRI) Med (95% CRI) Med (95% CRI) Med (95% CRI)
Age 0.99 (0.98, 1.01) 1.01 (0.98, 1.03) 1.02 (1.01, 1.03) 1.01 (1.00, 1.03)
Sex
Female
Male 1.14 (0.71, 1.85) 0.94 (0.53, 1.63) 1.17 (0.86, 1.61) 0.81 (0.61, 1.08)
Race
Non Malay
Malay 1.17 (0.61, 2.29) 1.31 (0.75, 2.36) 1.47 (1.08, 2.06) 1.47 (1.02, 2.07)
Education
Nil
Primary 0.38 (0.16, 0.94) 0.37 (0.14, 0.93) 1.36 (0.75, 2.45) 1.17 (0.69, 1.97)
Secondary 0.18 (0.08, 0.43) 0.33 (0.11, 0.92) 2.38 (1.26, 4.63) 0.94 (0.54, 1.59)
Tertiary 0.13 (0.05, 0.36) 0.06 (0.01, 0.45) 0.52 (0.18, 1.37) 0.43 (0.17, 0.98)
Missing 0.46 (0.23, 1.01) 0.76 (0.36, 1.52) 2.65 (1.49, 4.73) 0.92 (0.61, 1.44)
Smoking status
Non Smoker
Former Smoker 0.90 (0.48, 1.77) 1.25 (0.58, 2.96) 1.65 (0.96, 2.68) 1.88 (1.15, 2.92)
Active smoker 0.72 (0.30, 1.55) 1.89 (0.82, 4.49) 0.94 (0.60, 1.49) 1.07 (0.68,1.76)
Missing 0.77 (0.44, 1.36) 0.88 (0.47, 1.62) 1.06 (0.71, 1.57) 1.16 (0.81, 1.63)
Staging
Stage I
Stage II 0.47 (0.12, 2.09) 2.79 (0.97, 10.7) 0.85 (0.35, 2.35)
Stage III 3.30 (1.35, 8.69) 1.50(0.41, 6.19) 3.20 (1.15, 11.8) 1.34 (0.60, 3.65)
Stage IV 6.59 (2.58, 19.14) 1.31 (0.36, 5.51) 7.11 (2.62, 27.1) 3.19 (1.38, 8.48)
Not staged 1.22 (0.39, 4.05) 0.81 (0.16, 4.19) 2.62 (0.87, 9.79) 1.68 (0.71, 4.85)
Missing 6.53 (2.69, 17.66) 1.31 (0.39, 5.02) 4.29 (1.56, 15.5) 1.85 (0.83, 4.91)
Cancer Site
Colon
Rectum 0.88 (0.51, 1.45) 1.27 (0.57, 2.64) 0.85 (0.55, 1.38) 1.14 (0.73, 1.7)
Rectosigmoid 1.10 (0.67, 1.73) 0.82 (0.45, 1.39) 1.25 (0.95, 1.69) 1.20 (0.89, 1.63)
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Table 4.5: Table of parameter estimates from the fitted model for four states in
Malaysia. Significant estimates (those whose credible interval does not contain
1) are given in bold font for ease of identification.
Kelantan(N=268) KLumpur(N=290) Kedah(N=556) Sarawak(N=588)
Variable Med (95% CRI) Med (95% CRI) Med (95% CRI) Med(95% CRI)
Tumor grade
Moderate 2.18 (1.02, 5.88) 2.74 (1.08, 8.00) 1.48 (0.83, 2.77) 1.98 (1.11, 3.64)
Poor 2.24 (0.54, 8.88) 7.38 (1.49, 48.0) 1.94 (0.69, 4.92) 4.92 (2.03, 12.4)
Missing 3.10 (1.31, 8.26) 3.38 (1.31, 11.7) 1.88 (1.06, 3.70) 2.82 (1.48, 5.42)
Metastasis
No
Yes 1.08 (0.64, 1.82) 2.50 (1.30, 5.02) 1.58 (1.08, 2.29) 1.44(0.98, 2.16)
Missing 0.86 (0.38, 2.12) 2.12 (0.85, 5.36) 1.41 (0.83, 2.47) 1.36 (0.85, 2.28)
Treatment
Surgery Alone
Surg,Chemo,radio 0.59 (0.37, 0.95) 1.15 (0.63, 2.21) 0.71 (0.481, 1.03) 0.90 (0.64, 1.26)
Radio,Chemo 1.50 (0.57, 3.42) 2.52 (0.99, 6.33) 0.62 (0.29, 1.27) 1.06 (0.67, 1.69 )
Other 1.97 (0.496, 3.69) 4.75 (1.54, 15.02) 1.83(0.95, 3.63) 1.37 (0.19, 5.12)
Unknown 1.37 (0.62, 2.84) 1.76 (0.71, 4.52) 0.89 (0.56, 1.40) 1.75 (1.01, 2.94)
Diabetes
No
Diabetes 1.46 (0.87, 2.31) 1.21 (0.66, 2.24) 0.84 (0.60, 1.19) 1.01 (0.68, 1.48)
Missing 0.57 (0.30, 1.01) 0.91 (0.42, 1.95) 0.91 (0.54, 1.56) 0.98 (0.35, 2.22)
σ 0.55 (0.33, 0.88) 1.32 (0.92, 1.88) 0.54 (0.311, 0.83) 0.38 (0.20, 0.65)
φ 5010 (2285, 11241) 776 (495, 1309) 3839 (1617, 8458) 16384 (5828, 44570)
Spatial Survival Analysis 107
4.3.2 Maps for Probability of Exceedance Risk
We produced maps of the probability that hazard of death exceeds 1.1 and 1.25
for areas within the four states. The choice of the hazard values to exceed was
arbitrary and solely for illustrative purposes.
The risk maps for the three states in Peninsular Malaysia are shown in Figure 4.5.
Within Kelantan and Kedah, there were more regions displayed as at highest risk
of their hazard exceeding 1.1 than there were when the threshold was increased to
1.25. However, the threshold increase did not cause much difference in the number
of areas at highest risk within the Kuala Lumpur region, though we note that very
few areas in Kuala Lumpur, the capital of Malaysia, had a probability higher than
0.25 of having hazard of death exceeding either threshold.
Figure 4.6 shows exceedance risk maps for Sarawak, the chosen state in East
Malaysia. We see that very few areas of Sarawak are likely to have a hazard of
death exceeding 1.25.
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Figure 4.5: The leaflet plot of P[exp(Y ) > 1.1] (left) and P[exp(Y ) > 1.25]
(right) for Kelantan (top), Kedah (middle row) and Kuala Lumpur (bottom)
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Figure 4.6: The leaflet plot of P[exp(Y ) > 1.1] (left) and P[exp(Y ) > 1.25]
(right) for Sarawak, East Malaysia



















4.3.3 Baseline Hazard and Spatial Correlation
Next, we provide plots of the baseline hazard function and the posterior spatial
correlation function across space for each region, as shown in Figures 4.7, 4.8,
4.9 and 4.10. The baseline hazard function shows the shape of the hazard when
the covariates are all equal to zero. The shape of the baseline hazard in the plot
below describes a very slightly decreasing trend. The decrease in hazard was so
slight that we might consider an exponential model instead, however the WAIC
was lower for the Weibull model which indicates that this model is a better fit for
the data.
The spatial correlation function shows how similar the hazard is across space,
and how fast that similarity decays. A correlation plot with a fast drop (small
φ) shows that there is only little dependence in hazard with distance. On the
other hand, if the correlation plot has a slow drop, this shows that there is strong
spatial dependance in the hazard. It means that even though there may be a large
distance between places, the correlation in their hazard is high. The interpretation
of φ is that for distances over φ apart, there is little dependence in space.
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Kuala Lumpur had the smallest φ value and Sarawak the biggest φ value, as
presented in Table 4.5. The plot shows that the posterior covariance function for
Kuala Lumpur is fast to decay, indicating that spatial correlation exists within
small distances while in Sarawak the correlation in space can extend to areas a
long way away, even to 20km apart.
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Kelantan





















































Figure 4.7: Plots of the baseline hazard function (left) and posterior spatial
covariance function for Kelantan
Kedah





















































Figure 4.8: Plots of the baseline hazard function (left) and posterior spatial
covariance function for Kedah
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Kuala Lumpur





















































Figure 4.9: Plots of the baseline hazard function (left) and posterior spatial
covariance function for Kuala Lumpur
Sarawak



























































Figure 4.10: Plots of the baseline hazard function (left) and posterior spatial
covariance function for Sarawak
4.3.4 District Level Analysis
Analysis at the district level involved the creation of two spatial survival models,
one for Peninsular (West) Malaysia and one for East Malaysia. Table 4.6 shows
the relative risk of covariates used in these models. After controlling for spatial
location and socioeconomic factors, cancer staging still plays an important role
in determining the risk of death from colorectal cancer in Malaysia. Patients
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diagnosed at Stage IV had six times (median 6.37, 95% CRI (4.34, 9.75)) and seven
times (median 7.33, 95% CRI (2.99, 24.00)) higher risk of death from colorectal
cancer in West and East Malaysia respectively than patients diagnosed at Stage
I. Each year increase in age led to a slight increase (median 1.01, 95% CRI (1.01,
1.02)) in relative risk of death. Other factors that significantly affect survival in
colorectal cancer patients in Malaysia were race, tumour differentiation and the
presence of distant metastases.
We included two parameters to represent the socioeconomic distinctions in the
population; the intensity of the hospitals in each district and the middle class
household item index (socioeconomic index). However the socioeconomic index
was only available for Peninsular Malaysia. Both of these variables showed a
decrease in the risk of death as the value of the parameters increases, however
neither result was significant.
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Table 4.6: Table of parameter estimates from the fitted model. Significant
estimates (those whose credible interval does not contain 1) are given in bold
font for ease of identification.
Pen. Malaysia East Malaysia
Covariates Med (95% CRI)% Med (95% CRI)%
Age 1.01 (1.01, 1.02) 1.01 (1.01, 1.02)
Sex
Female
Male 1.05 (0.93, 1.19) 0.96 (0.76, 1.24)
Missing 0.81 (0.40, 1.42) 0.60 (0.02, 5.29)
Race
Non Malay
Malay 1.26 (1.13, 1.43) 1.47 (1.05, 2.01)
Missing 1.24 (0.20, 4.58) 1.53 (0.27, 5.87)
Education
Nil
Primary 0.92 (0.72, 1.17) 1.00 (0.68, 1.46)
Secondary 1.00 (0.78, 1.27) 1.01 (0.68, 1.47)
Tertiary 0.63 (0.43, 0.88) 0.60 (0.32, 1.10)
Missing 1.03 (0.85, 1.28,) 0.82 (0.61, 1.18)
Smoking
Non Smoker
Former Smoker 1.17 ( 0.97, 1.40) 1.45 (0.99, 2.00)
Active smoker 1.13 ( 0.93, 1.37) 1.12 (0.76, 1.63)
Missing 1.03 (0.90, 1.19) 1.09 (0.80, 1.50)
Staging
Stage I
Stage II 1.65 (1.09, 2.57) 2.04 (0.81 ; 6.85)
Stage III 3.17 (2.13, 4.83) 3.63 (1.43,10.90)
Stage IV 6.37 ( 4., 9.75) 7.33 (2.99,24.00)
Not staged 2.79 (1.88, 4.46) 5.06 (2.03, 16.00)
Missing 4.14 (2.82, 6.45) 3.91 (1.56, 12.70)
ICDSite
Colon
Rectum 1.05 (0.90 ; 1.23) 1.32 (0.95 ; 1.84)
Rectosigmoid 1.06 (0.94 ; 1.19) 1.16 (0.89 ; 1.49)
Missing 0.29 (0.01 ; 1.52)
TumourDiff
Well
Moderate 1.17 ( 0.94, 1.46) 1.77 (1.08, 3.01)
Poor 2.45 (1.81, 3.40) 2.99 (1.46, 5.88)
Missing 1.59 (1.28, 1.99) 2.84 (1.73, 4.97)
Metastasis
No
Yes 1.40 (1.21, 1.62) 1.59 (1.19 ; 2.13)
Missing 1.47 (1.21 ; 1.77) 1.39 (0.93, 2.11)
Treatment
Surgery Alone
Surg,Chemo,radio 0.87 (0.76, 0.99) 0.98 (0.75, 1.27)
Radio,Chemo 1.11 (0.91, 1.35) 1.22 (0.83, 1.81)
Other 1.84 (1.41, 2.38) 2.36 (0.99, 4.96)
Unknown 1.13 (0.95, 1.33) 1.56 (0.99, 2.35)
Diabetes
No
Yes 1.12 (0.99, 1.28) 1.08 (0.77, 1.43)
Missing 0.88 (0.72, 1.06) 0.73 (0.28, 1.56)
Hosp. intensity 0.97 (0.81, 1.143) 0.69 (0.03, 13.70)
SE Index 0.85 (0.53, 1.39)
σ 0.38 (0.20, 0.65) 0.51 (0.34, 0.74)
φ 16384 (5828, 44570) 44602 (24370, 78650)
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Figure 4.11: Plots of the baseline hazard function (left) and posterior spatial
correlation function for Peninsular Malaysia. Plot shows that the correlation of
hazard starts to decrease when the distance of cases was reaching 20km apart;
supported by φ value in Table 4.6






























































Figure 4.12: Plots of the baseline hazard function (left) and posterior spatial
correlation function for East Malaysia. Plot shows that the correlation of hazard
starts to decrease when the distance of cases was reaching 45km apart; supported
by φ value in Table 4.6
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4.3.5 Maps for Probability of Exceedance Risk - District
Level
Figure 4.13 shows the risk map for the probability of exceedance risk of hazard
of 1.1 and 1.25 in Peninsular Malaysia. These plots show P[exp(Y ) > 1.1] and
P[exp(Y ) > 1.25]. Three regions in Peninsular Malaysia were identified as having
a higher probability that the hazard of death would exceed 1.1, that is, those with
probability greater than 0.75 of exceeding the stated hazard. The probability
starts to lessen when we increase the exceedance threshold to 1.25.
Figure 4.14 shows the risk map for the probability of exceedance risk of hazard of
1.25 and 1.5 in East Malaysia. East Malaysia has two states, Sabah and Sarawak.
The areas of highest probability of exceeding the stated hazard of death in East
Malaysia were all located in Sarawak. There was one district in Sarawak, Limbang,
that was highly likely to have a hazard of death exceeding 1.25. Upon increasing
the threshold to 1.5, only one part of the Sarawak region continues to have proba-
bility of exceedance between 0.50 to 0.75, and none with probability greater than
0.75.
Figure 4.13: The leaflet plot of P[exp(Y ) > 1.1] (left) and P[exp(Y ) > 1.25],
Peninsular Malaysia
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Figure 4.14: The leaflet plot of P[exp(Y ) > 1.25] (left) and P[exp(Y ) > 1.5],
East Malaysia
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4.4 Discussion
In this study, we extend the survival model from our previous objective to look at
the geographical variation of colorectal cancer survival in Malaysia. Our findings
show that there is a spatial variation in survival prognoses, or the hazard of death,
for colorectal cancer in Malaysia even having adjusting for individual level and
area level covariates.
Overall, from the point location analysis, we noted that the level of disease severity
as measured by cancer staging, tumour grading and the presence of distant metas-
tases, remain as important predictors of survival times for patients with colorectal
cancer in Malaysia even after controlling for spatial correlation. Survival is also
better in patients with higher levels of education.
Our results for the district level analysis for both Peninsular and East Malaysia
were not much different from the point level analysis. Cancer staging, tumour
differentiation and the presence of distant metastases continue to have a significant
effect on survival for colorectal cancer patients. We also see here, though, that
Malays had a significant 26% higher risk of dying from colorectal cancer than
non-Malays. An increase in age slightly increased the risk of death from colorectal
cancer.
We found that high socioeconomic index in an area did not significantly affect the
risk of death from colorectal cancer. Our findings were similar to those of Barclay
et al. (2015) who found that the socioeconomic status of the population did not
significantly influence outcomes in patients with colorectal cancer. In comparison,
a systematic review by Manser and Bauerfeind (2014) found that socioeconomic
status had a significant impact on survival of colorectal cancer, where the risk
of death was greater among patients with low socioeconomic status. Regarding
socioeconomic status, recall that our measure, based on the 2000 census, was
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aggregated to district level. Hence a potential explanation for not observing a
significant effect may be due to the presence of ecological bias: that our mea-
sure of socioeconomic status did not pertain to individuals. In fact, considering
that education is often directly related to socioeconomic status, our results do
therefore show evidence that higher socioeconomic status is protective. However,
further research in this area is required, and a more finely-resolved spatial map of
deprivation could help us to better identify this effect.
It is possible that there is collinearity between our variable ‘education’, an indi-
vidual level variable, and our socioeconomic index, which is an area level factor
measure one of whose domains is education. We think that this two measures
are not likely to be well correlated for the following reasons. Socioeconomic index
includes a measure, at an area level, of the proportion of population with tertiary
education in a district (area level). Education is one of five domains of which
the socioeconomic measure is comprised. We realized the education might driven
to the socioeconomic status, but in is not the sole driver of socioeconomic. The
widely used UK Index of Multiple Deprivation (IMD) is comprised of 7 domains,
one of which is based on education, and the index measures to the small areas
across England, called Lower-Layer Super Output Areas (LSOAs) (Ministry of
Housing, Communities Local Government UK, 2015).
The education variable in the model represents the individual education level of
the patients in this study, classified into five categories, nil, primary, secondary,
tertiary and missing status. Thus we think that the education and the SE index
variable in the model represent different things. To see if this is likely, we checked
if there was any correlation between the two variables but it was not significant
with the correlation coefficient, ρ=0.01.
We noticed that there were patients that had changed their address to another
place after diagnosis, we decided not to choose the distance of the patients address
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to the hospital as our measure of accessibility to healthcare. Address at diagnosis
is important as an ‘exposure’ or proxy for umeasured exposures, but we had no
record of length of residence at the address at diagnosis, leaving open the likelihood
of misclassifying cases by exposure to place. For example people move house or job
for many reasons, but sometimes for health reasons. They may for example move
nearer a hospital when ill, or away from an exposure when concerned and there is
evidence that population movement can lead to misclassification in epidemiological
studies, such as when birth address is used in studies of birth defects (Canfield
et al., 2006). Instead, we decided to look at how the density of the hospital in the
area affect the patients’ survival in our study.
The relationship between survival and distance to treatment hospital is not clear
cut: it is not necessarily the closest hospital to patients that they will choose
to go to seeking treatment and for this reason, we use the smoothed intensity
(number of hospitals per unit area) as a covariate in our model. We expect the
coefficient of this covariate to be positive, since, in places where there is a greater
concentration of hospitals, patients tend to get diagnosed quicker by being able
to recognise and act on early symptoms. We found that greater accessibility to
healthcare decreased the risk of death from colorectal cancer but the effect was not
significant in our study, which contradicts a previous study reporting that lack of
access to healthcare was significantly associated with being diagnosed at a more
advanced stage of colorectal cancer (Wan et al., 2013), which we know adversely
affects patient survival. Different ways of assessing accessibility to healthcare may
influence the direction and significance of the effect. For example, the previous
study measured the shortest time taken to travel to the nearest appropriate health
facility, while our study measured the number of hospitals per unit area. Further-
more, other factors that could be mediators to the accessibility to healthcare, such
as the transportation system, affordability of care and cultural barriers, were not
considered in our study.
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Regarding the exceedance probabilites, some areas of Kuala Lumpur remain more
likely than others to exceed a relative risk of death of 1.1 and 1.25. This might
warrant further investigation as to why certain places in the capital city had lower
survival rates than others. However, note that our point level analysis only con-
trolled for individual risk factors. Therefore, the environment or area level factors
such as socioeconomic status (Lejeune et al., 2010) and accessibility to healthcare
(Wan et al., 2013) might also affect spatial variation in survival.
Three areas were found to have high risk of death (where the HR > 1.1 relative
to other areas in Peninsular Malaysia). They were Jeli district in the North-
East, Kinta district in the North-West and Melaka Tengah located in the West
of Peninsular Malaysia. In East Malaysia, Sabah had better survival compared
to Sarawak as shown by the probability of exceedance risk maps. The reason for
these differences could be such things as delay in chemotherapy treatment (Xu
et al., 2014) and comorbidities (Søgaard et al., 2013) which were not assessed in
our study, and this would make an interesting direction for further work in this
area.
There are some limitations to the work of this study. One of the limitation of
this study is that we could not locate exactly the address for all cases study,
the result of incomplete documentation of full address in the registry database.
For records where there was an incomplete addresss recorded researcher had to
locate the addresses manually as been explained in the methodology section and
try and make the best effort possible to find the most accurate approximated
address possible. The accuracy of the patients’ location varies across the states
and this may possibly affect our analysis in a state with very low accuracy, which
in this case is Kelantan. Uncertainty in the spatial location affects our ability to
estimate the spatial correlation parameter in our model, which is typically not
well identified in spatial analyses in any case. It is possible to account for the
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uncertainty in location in a formal manner - see the conclusions chapter, but this
is beyond the scope of this thesis.
Malaysia does not have a formal socioeconomic status instrument consistent across
the population (for example, the UK have an index of deprivation). Currently the
Malaysian Statistics Department only produce data on income at the district level;
data on income at finer levels does not exist. We hope that in future research, it
will be possible to consider household income and employment status as additional
indications of socioeconomic status.
There are several strengths of spatial analysis method used here. First it allows
us to combine data from the individual level with data from aggregated levels and
map our findings. It also allows us to estimate and map the effect of unobserved
environmental confounders through the use of a spatially correlated random effect
term. We applied MCMC for our analysis as it delivers full joint inference for all
model parameters. Some limitations to be considered is that this analysis assumes
a particular model form and correlation structure for the spatial variation and
that it can be difficult in practice to identify the parameters of the spatial process.
Attaining good convergence and mixing of MCMC can be difficult without access
to bespoke software ? but again this is not a issue for us.
Despite these limitations, this is the first study examining the variation in survival
for colorectal cancer in Malaysia. There is variation in the survival or risk of death
from colorectal cancer in the population, having control for the potential individual
and area level factors. Areas close to town centers including the urban areas had
lower risk of death compared to other areas in all four states chosen to be in our
point analysis model. In the state level analysis, out of 144 districts in the whole
of Malaysia, we identified 4 districts, three in Peninsular Malaysia and one in East
Malaysia which had higher risk of death compared to the others. Our findings
are a new input for the ministry of health to set a target for the population with
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high risk of having poorer survival in providing cancer control services as well as
enhance health activities that are cancer-reated in order to improve survival in the
population.
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Appendix I: Diagnostic Test
KELANTAN:
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































MCMC convergence from trace plots
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Figure 4.19: Priorposterior plots
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Chapter 5
Modelling Incidence of Colorectal
Cancer In Peninsular Malaysia
5.1 Introduction
Cancer is recognised as a major health burden across the world, as discussed in
Section 2.3. Of the 14.1 million new cases of cancer diagnosed every year, around
1.36 million (9.7%) are new cases of colorectal cancer. This number is expected
to increase by 80% by the year 2035 to approximately 2.4 million new colorectal
cancer cases which will contribute to 1.3 million deaths worldwide (Douaiher et al.,
2017).
Incidence of colorectal cancer varies widely geographically, with some countries
exhibiting incidence rates 10 times larger than other countries. Australia/New
Zealand have the highest rates of incidence with age standardized rates of 44.8
and 32.2 per 100,000 population in men and women respectively, while the lowest
incidence was reported in Western Africa with comparative rates of 4.5 and 3.8
per 100,000 in men and women respectively. Similar patterns of colorectal cancer
incidence were found in both sexes (Ferlay et al., 2015).
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The incidence of colorectal cancer is higher in developed Asian countries such as
Japan, Singapore and Korea than in developing Asian countries such as Thailand
and India (GLOBOCAN, 2012). It is important to evaluate geographical (spa-
tial) variation in incidence and risk factors affecting cancer incidence in order to
(1) identify high risk populations, (2) help to prioritise the target population for
screening and (3) facilitate health intervention.
There are several possible influences on the spatial variation in colorectal cancer
incidence. Differences in risk factors such as eating habits, lifestyle (Li et al.,
2017), socioeconomic status (Doubeni et al., 2012a, Jandova et al., 2016, Singh
and Jemal, 2017) as well as race and genetic factors (Sung et al., 2005) may
result in the geographical variation in colorectal cancer incidence that we observe.
Disparity of screening policies, practices and rates among countries may lead to
variation in colorectal cancer incidence; partly because increased screening may
lead to increased detection of cancers (Li et al., 2017, M.M.Center et al., 2009),
and also because screening rates have previously been linked with accessibility
to healthcare. Areas with good accessibility to healthcare are reported to have
higher cancer incidence than in areas living with limited accessibility to healthcare,
including screening centres (Hao et al., 2009, Jackson et al., 2016).
Findings from previous studies in Malaysia show that the distribution of colorectal
cancer varies within the country. Shah et al. (2014) observed the spatial variation
of colorectal cancer cases by subdistrict or small counties, stage of cancer and eth-
nicity in Kuala Lumpur, Malaysia. The ethnicity of the cases was predominantly
Chinese. The ‘hot spots’ were located in the North-West areas of the city and the
‘cold spots’ in the north east. The researchers discussed that this was probably
due to the socioeconomic disparities between the areas, whereby the North-West
had better socioeconomic status than the north east. However, no spatial mod-
elling was employed in identifying the variation. Additionally, they suggested that
the lack of mass screening to detect colorectal cancer among the population as
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the possible cause for the low incidence in the cold spot areas, but they did not
provide any evidence to support this.
The spatial distribution of colorectal cancer cases has also been described in the
north (Penang) (Samat et al., 2013) and the east (Kelantan) of Peninsular Malaysia
(Samat and Shattar, 2014). These researchers investigated the geographic distribu-
tion of colorectal cancer cases, sought to identify spatial clustering, and evaluated
the spatial accessibility to healthcare facilities for these patients. They found that
there were high numbers of cases concentrated in the main city centres, probably
due to better accessibility of the population to screening facilities.
Our study aims to build on previous epidemiological research into colorectal cancer
in Malaysia and the region. We aim to model the number of colorectal cancer cases
in the four states : Kedah, Perlis, Penang and Perak, located in the North-West of
Peninsular Malaysia. According to the data provider, these four states have near
complete case ascertainment. We also aim to map the probability that the relative
risk exceeds certain threshold, see section 5.3.3. Lastly, we will use the model to
predict incidence in areas of Peninsular Malaysia where there is incomplete case
ascertainment.
Our model, which is derived from the log-Gaussian Cox process (Diggle et al., 2013)
can be conceptualized as a Generalized linear mixed effect model with spatially
correlated random effects. This will be explained further in this Methods section.
We will use point-located data in our analysis, aggregated to a fine grid, covering
our study region. Using this ‘complete data’ model, we extrapolate our findings to
the rest of Peninsular Malaysia and also discuss how to improve these predictions
using model-based methods.
To the best of our knowledge, this is the first cancer research in Malaysia that
uses spatial modelling to identify potential risk factors for colorectal cancer in
Malaysia, as well as mapping those risks and predicting incidence in new areas.
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The outcome of this study will be a valuable resource for healthcare providers, by
helping them to anticipate demand for resources in identified high risk locations.
It will also support the Cancer Registry in helping to understand how to improve




The four Peninsular Malaysia states considered as having near complete case-
ascertainment rate are Kedah, Penang, Perak and Perlis, and are shown in Figures
5.1 and 5.2. These states comprise the study area in which we will model the
colorectal cancer incidence. The total population of these areas is almost 6 million
people (census2010), and is principally Malay (58.1%), with 26.8%, 9.4% and 1.9%
of the population identifying as Chinese, Indian or other race respectively. 3.8% of
the population were non-citizens of Malaysia; these were excluded from our study.
Figure 5.1: Black border regions shows the 28 regions within the studied 4
states (North-West Peninsular Malaysia) from Malaysia map
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Figure 5.2: North-West Peninsular Malaysia
5.2.2 Data Description
The data used for this chapter comprise the colorectal cancer cases diagnosed
between 2008 to 2013 in the North-West of Peninsular Malaysia. After excluding
seven cases without address information, there remain 1248 colorectal cancer cases
from these four states (556, 379, 247 and 69 cases in Kedah, Penang, Perak and
Perlis respectively). These 1248 cases represent 39.6% of all colorectal cancer cases
in Peninsular Malaysia.
For this chapter, we used each patient’s geographical location for analysis. We
applied the same procedure for acquiring the coordinate location of the cases as
we did in Chapter 4, that is, we searched for the coordinates of the point locations
given by the addresses available in the data. We used Google Maps, 1MalaysiaMap
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(MaCGDI, 2012), and other resources from Google to search for the coordinates
of the addresses. For those individuals where no address coordinate was available
through the above databases, we generated an approximate address. We started
with small street (of length less than 1km) to housing area to village to ‘mukim’
(sub-division of district) as also explained in the previous chapter (Table .
We used the 2010 data from Worldpop as the source of our population data for the
analysis (Worldpop, 2017). These are raster data of 100m resolution. We projected
the Worldpop data onto our region and aggregated it to a regular square grid of
4km sides. For the analysis, the number of people in each grid cell represent the
population at risk.
Table 5.1: Table of percentage(%) addresses assigns in the North West of
Peninsular Malaysia
States Accurate address(%) Small street Village(%) Small mukim(%) Total %
Penang 84.9 6.9 8.2 0.0 100
Kedah 65.0 10.0 19.0 6.0 100
Perlis 37.8 4.3 57.9 0.0 100
Perak 61.6 12.1 24.7 1.6 100
We chose three explanatory variables to be evaluated as potential predictors for
colorectal cancer incidence. They were:
• level of health service provision; determined using the number of hospitals
per unit area as a proxy.
• a measure of socioeconomic status
• the proportion of Chinese people in the population
We have explained how we derived the value of hospital intensity and socio-
economic index in Chapter 4. We chose the proportion of Chinese people as a
predictor because this race had the highest age standardised incidence rate of col-
orectal cancer in Malaysia in a previous study (Hassan et al., 2016). This agrees
with the analysis of colorectal incidence by race described in results section 5.3.1.
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5.2.3 Statistical Analysis
5.2.3.1 Modelling Incidence of Colorectal Cancer
We modelled the number of colorectal cancer cases for the four states in North-
West Peninsular Malaysia over the six year period 2008 to 2013.
As mentioned earlier, we used a point process model, fitted using the R software
package lgcp (Taylor et al., 2015). It is a generalised linear mixed effects model
in which the number of cases takes a Poisson distribution. The observed number
of cases is explained by the chosen fixed effects (socioeconomic status, hospital
intensity, proportion of Chinese people) and spatially correlated random effects.
The model, also known as the spatial log-Gaussian Cox process is as follows:
X(s) ∼ Poisson {R(s)}
R(s) = CA exp {α logP (s) + Z(s)β + Y (s)}
logR(s) = log(CA) + α logP (s) + Z(s)β + Y (s)
X(s) denotes the observed number of cases (counts) in the grid cell containing
spatial location s. CA is the cell area . We chose to use the covariate transformation
logP (s) in the model to give a more flexible relationship between population and
the number of cases (rather than just assuming proportionality as is common for
Poisson models). If it transpires that α ≈ 1, then this, in essence similar to
including P (s) as an offset in the Poisson model. Z(s) is a vector of area level
covariates (fixed effect) with associated effect β. Y (s) is a spatial random effect.
The interpretation of Y (s) is that having accounted for the fixed effects, Y (s)
represents variation in risk not accounted for by the effects. We assume that
Y (s) is similar at locations S1 and S2 that are close to each other, but nearly
uncorrelated for S1 and S2 that are far apart. We use an exponential model to
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describe the decay in correlation for two points. S1 and S2 that are distance d
apart, we assume corr(Y (S1), Y (S2)) = exp
−d
φ
for some parameters φ > 0. We
further assume the marginal variance of Y is σ2 > 0.
We normalized the area level covariates chosen for the model as we want to see
which factors had the biggest affect on colorectal cancer cases in our study.
5.2.3.2 Prediction
In order to predict the expected number of cases outside the region used to create
the model, or, to be exact, for the whole of Peninsular Malaysia, we need estimates
for all terms in the model, CA, λ(s), Z(s), β, α, φ, σ
2 and Y (s). Note that outside
North-West Peninsular Malaysia, our predictions are extrapolations and should
be treated with some caution.
We arrange the prediction grid so that it is an extension of the grid previously
used for analysis. Therefore, the grid we used in North-West Peninsular Malaysia
is a subset of the grid covering all of Peninsular Malaysia. The main complication
with producing extrapolated predictions of the expected number of cases concerns
the process Y . Since Y is correlated spatially, producing these predictions would
require repeated inversion of a very large matrix which is beyond the scope of
desktop computers.
Our model assumes that E(Y (s)) = −σ2
2
for any s, as this is how Y is parameterized
in the package lgcp used to fit these data (Taylor et al., 2015). Therefore, rather
than simulate a correlated Y on the area outside North-West Peninsular Malaysia,




σ2 for each retained sample of σ from the MCMC chain used to fit the model.
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We also sought to obtain an estimate of incidence of cases of colorectal cancer
across the whole of Peninsular Malaysia. To do this, is in principle, straightfor-
ward from our model; it just involves aggregating the predicted number of cases in
each cell over Peninsular Malaysia and dividing by the population at risk. How-
ever, this is complicated by the fact that the National Patient Cancer Registry -
Colorectal Cancer database is known to be incomplete beyond North-West Penin-
sular Malaysia. Each sample i of our MCMC chain, (α(i), β(i), σ(i), φ(i)) yields a
different prediction of the total number of cases, Ti. Since we observed T
∗ = 3155
cases in our database, we know that the T must be > T ∗. Therefore in our pre-
diction for the total number of cases, we give inference for max[Ti, T
∗], including
a confidence interval.
We then mapped the predicted incidence for colorectal cancer for the whole of
Peninsular Malaysia. We were aware of the uncertainty of the prediction presented
in the map, hence we created another plot, a plot of the posterior probability that
the incidence in each area exceeds the national average. All this is shown in results
section 5.3.4. We also predict the mean case ascertainment rate across the whole
of Peninsular Malaysia with a 95% credible interval, calculated as the number of




The Malaysian colorectal cancer patients in our data identify as ethnically Malay,
Chinese or Indian. Table 5.2 shows the proportion of the population (number
and percentage) of each race in North-West Peninsular Malaysia. The Malay
are the main race in this region, comprising between 56.5 and 93.2% of the total
population in these four states. Indians are the least populous in all four states. In
all states but Perak, Indian people make up less than 10% of the population. The
proportion of the population with Chinese ethnicity is almost equal in Perak and
Penang (30% and 32% respectively), but in Kedah and Perlis, people of Chinese
origin make up just 16.5% and 5.5% of the total population respectively.
Table 5.2: Population by race in NorthWest Peninsular Malaysia, n (%)
Kedah Perlis Perak Penang
Malays 394975 (74.8) 55053 (93.2) 216281 (56.5) 100519 (59.7)
Chinese 87510 (16.6) 3241 (5.5) 117023 (30.6) 54114 (32.2)
Indians 45259 (8.6) 794 (1.3) 49431 (12.9) 13691 (8.1)
Total 527744 (100) 59088 (100) 382735 (100) 168324 (100)
Table 5.3 shows the ethnic proportions among patients with colorectal cancer in
North-West Peninsular Malaysia between 2008 and 2013.
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Table 5.3: Colorectal cancer cases by race in North-West Peninsular Malaysia
Kedah Perlis Perak Penang
Malays 337 (60.2) 49 (74.2) 115 (46.6) 112 (29.6)
Chinese 170 (30.4) 17 (25.8) 111 (44.9) 232 (61.2)
Indians 53 (9.5) No cases 21 (8.5) 35 (9.2)
Total 560 (100) 66 (100) 247 (100) 379 (100)
Next, we calculate the age standardised incidence rates by race for colorectal
cancer patients diagnosed between 2008 to 2013, see Table 5.4. Among these
states, Kedah has the highest overall age standardised incidence rate with 5.6 (5.2,
6.1) per 100 000 population per year and Perak has the smallest age standardized
incidence rate with 1.8 (1.5, 1.9) per 100 000 population per year. Those of
Chinese ethnicity had the highest age standardised incidence of colorectal cancer
for all four states in the North-West of Peninsular Malaysia. We note that there
were no cases of colorectal cancer from patients of Indian ethnicity in Perlis, most
likely because it is a small region with a small proportion of Indian people living
there.
Table 5.4: Age standardized incidence rates by race of colorectal cancer be-
tween 2008 to 2013 (per 100 000 population)
Incidence rate (95%CI)
Kedah Perak Perlis Penang
Overall 5.6 (5.2,6.1) 1.8 (1.5,1.9) 5.2 (4.0,6.5) 4.5 (4.0,4.9)
Malay 4.6 (4.1,5.1) 1.7 (1.4,2.1) 4.4 (2.9,5.9) 4.0 (3.3,4.8)
Chinese 9.5 (8.1,10.9) 1.9 (1.6,2.3) 11.7 (6.1,17.3) 4.8 (4.2,5.5)
Indian 6.2 (4.3,8.1) 1.4 (0.8,1.9) No cases 4.3 (2.8,5.7)
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5.3.2 Modelling the Risk of Colorectal Cancer in North-
West Peninsular Malaysia
We used the R package lgcp (Taylor et al., 2015, 2013) to run MCMC until we
obtain satisfactory convergence. This was achieved with 1,000,000 iterations, an
initial burn-in of 10,000 iterations and thinning every 1000th sample. We looked
for evidence of good mixing and satisfactory convergence as follows.
To check for convergence and good mixing we examined trace plots and plots of
autocorrelation (Figures 5.4 to 5.6). Since these are marginal summaries, we also
produced a plot of the log-posterior(target) (Figure 5.3) over the duration of the
chain to check for global convergence (see Taylor et al. (2013)). For clarity, Figure
5.4 shows the lag 1, 5 and 15 autocorrelation for Y in each cell of the grid: it is
easier to visualize this way than examining thousands of traceplots by eye. For
α and φ, the most challenging parameters with which to achieve good mixing,
we also compared plots of the prior and posterior (Figure 5.7) to check how well
these were identified by our data. That the prior and posterior in both cases look
different is an indication that our data were able to identify both σ and φ. For all
other parameters in the model mixing was quick and convergence was confirmed
by visual inspection.
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Figure 5.3: Diagnosing convergence to a posterior mode: a plot of the
log(target)
Figure 5.4: Lag 1, 5, 15 autocorrelation plots (from left to right)
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Figure 5.5: Autocorrelation plots for log σ and log φ









































































Figure 5.7: Plots of the prior and posterior values of log σ and log φ
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Having ascertained satisfactory convergence, we proceed with making inferences
from the model. Table 5.5 summarises the parameter estimates from our model.
The variable that had the largest effect on incidence was hospital intensity: a
unit increase in normalised hospital intensity led to a risk 1.58 (CRI (0.82, 2.91))
times that of existing colorectal cancer cases in a place/area. A unit increase in
normalized value of socioeconomic index led to a 1.18 (CRI (0.58, 2.25)) increased
risk of colorectal cancer cases, and a unit increase in the proportion of Chinese
people in the population led to an increase in risk of 1.11 (CRI (0.64, 1.94)).
However none of the variables in the model were statistically significant.
A matter that complicates inference is that the socioeconomic index and the pro-
portion of Chinese people are correlated variables. We would like to keep both of
these variables in the model because we want to know the joint effect of both on
incidence of colorectal cancer. Therefore, interpretation of the coefficients of these
variables needs to be undertaken with care. In Figure 5.8 we present the effect of
these variables using a bivariate contour plot. For most of the areas, the effects of
both variables were not significant, (i.e the credible interval contained 1), however
the conditional effects were significant for low or high values of the other variable.
We explain in more detail about this in Appendix 5.4.
We also fit models where we include one of the variables individually and we found
that the effects were slightly larger and they were also only marginally insignificant,
with the vast majority of the credible interval greater than 1, see Table 5.6 and
Table 5.7.
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Table 5.5: Parameter estimates for the LGCP point pattern model for the
colorectal cancer data in North-West Peninsular Malaysia
median lower 95% CRI upper 95% CRI
σ 1.69 1.44 2.07
φ 13137 9074 21073
exp(βIntercept) 5.9×10−10 2.59×10−10 1.32×10−9
exp(α) 2 1.8 2.24
exp(βHospIntensity) 1.58 0.816 2.91
exp(βseIndex) 1.18 0.583 2.25
exp(βChineseProp) 1.11 0.639 1.94
Table 5.6: LGCP Model 2: without the ‘proportion of Chinese’ variable
median lower 95% CRI upper 95% CRI
σ 1.72 1.48 2.05
φ 13438 9484 21674
exp(βIntercept) 5.95×10−10 3.57×10−10 1.56×10−9
exp(α) 2 1.81 2.18
exp(βHospIntensity) 1.50 0.925 2.46
exp(βSEIndex) 1.38 0.966 2.04
Table 5.7: LGCP Model 3: without ‘Socioeconomic index’ variable
median lower 95% CRI upper 95% CRI
σ 1.72 1.45 2.11
φ 14232 9796 21375
exp(βIntercept) 6.24×10−10 3.3×10−10 1.51×10−9
exp(α) 1.96 1.78 2.15
exp(βHospIntensity) 1.37 0.779 2.33
exp(βChineseProp) 1.29 0.951 1.82
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Figure 5.8: Contour plot showing the joint relative risk for SE index and the
proportion of Chinese ethnicity
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We checked the model fit by plotting the observed versus expected cases, shown
in Figure 5.9. We see that our model fits the data well.












Figure 5.9: Plot for model fit
5.3.3 Maps of Exceedance Probabilities
It is of scientific interest to identify areas that have particularly high risk, even
after adjusting for covariates. We can do this by plotting exceedance probabilities
on a map. We consider P[exp(Y ) > t] for t =1.5, 2.5 and 5; that is, the probability
that the relative risk is greater than 1.5, 2.5 and 5 over space.
Darker areas in the map highlight areas where it is likely that the relative risk
thresholds were exceeded. The left map shows that in some areas the probability
of the relative risk exceeding 1.5 is more than 0.75. There are a small number of
areas where there was evidence that the relative risk was greater than 5.
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Figure 5.10: Maps illustrating P[exp(Y ) > t] for t = 1.5, 2.5, 5 from left to
right

























5.3.4 Maps of Estimated Incidence of Colorectal Cancer
for Peninsular Malaysia
Figure 5.11 shows the predicted annual incidence per 100,000 population. Our
model predicts that the mean true incidence for colorectal cancer in Malaysia is
2.89 (95% CI (2.40, 5.25)) per 100,000 population per year. The plot shows that
the predicted incidence in the western region of Peninsular Malaysia was higher
than the eastern region. Taking into account the uncertainty in our predictions,
we produced a map of the probability that incidence exceeds the national average,
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shown in Figure 5.12. The map shows that the areas most likely to have an
incidence above the national average are around Kuala Lumpur and Penang.
Figure 5.11: Predicted incidence of colorectal cancer in Peninsular Malaysia

























Figure 5.12: Probability that incidence of colorectal cancer is above the na-
tional average


























5.3.5 Estimating the Case Ascertainment Proportion
As mentioned earlier, for areas outside North-West Malaysia there is incomplete
case ascertainment. By summing up the predicted numbers of cases per grid cell
over Peninsular Malaysia, we are able to form a prediction of the total number
of cases. Comparing this with the observed number of cases gives us the case
ascertainment rate.
Case ascertainment, CA = 100× observed number of cases
predicted number of cases
.
Each iteration of the MCMC algorithm gives us a different predicted number of
cases, say P (i) for the ith iteration. Therefore
CA(i) = 100× observed number of cases
maxP (i)
is our estimate of the case ascertainment based on the ith iteration and we can form
a credible interval in the usual way, which here gives an overall case ascertainment
rate of 93.1%, CRI (47.5%, 100%).
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5.4 Discussion
In this chapter, we used a log-Gaussian Cox process to model the observed number
of cases of colorectal cancer in Malaysia. We then constructed an estimate of the
annual disease incidence and also an estimate of the case ascertainment rate.
The intensity of hospitals per unit area, a socioeconomic index and the proportion
of Chinese population were not statistically significant in our model. We found
that the town centres and urban areas in North-West Peninsular Malaysia had
greater risk of having colorectal cancer cases relative to other areas.
Our use of hospital intensity per unit area as a factor affecting the number of
colorectal cancer cases in the area, is chosen for its relationship with accessibility of
healthcare or screening centres, which may influence cancer reporting. It has been
reported (Samat et al., 2013) that in Malaysia, the areas with better accessibility
to healthcare or screening facilities are likely to document more cases relative to
areas with lower accessibility. We found that the number of colorectal cancer
cases increased with increasing hospital intensity, which corroborates the previous
research, though we did not find this effect to be statistically significant. Further
research should seek to investigate better measures of screening provision in order
to confirm this, but these data were not available to us.
Our study found that socioeconomic index and the proportion of Chinese in the
area were positively correlated. We produced a bivariate density plot for these
covariates and found that neither of these variables were significantly associated
with the number of colorectal cancer cases in this study. This is similar to Lad-
abaum et al. (2014) who reported that the neighbourhood socioeconomic status
and ethnic enclave are highly correlated and are significantly associated with the
incidence of colorectal cancer among Asian populations in California. However,
their study did not involve spatial modelling to identify the associated factors and
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arguably, our model would give a better indication of the relationship with these
two variables if we had information at a finer spatial scale.
The map for probability of exceedance relative risk of colorectal cancer in North-
West Peninsular Malaysia shows variation in the risk for colorectal cancer cases
across the region. We noted that town areas are highly likely to exceed the thresh-
old of relative risk of increased number of colorectal cancer cases, and this effect is
present even though we account for the additional population there. Apart from
the variables for which we have controlled, knowledge of and attitude towards
screening for colorectal cancer also may affect the variation in the number of cases
in the country.
The Malaysian population was reported to have very low participation in colorectal
cancer screening (Yusoff et al., 2012). A study on the rural population in Malaysia,
found that the level of awareness of the risks and symptoms of colorectal cancer
was very low (Su et al., 2013). On the other hand, Naing et al. (2014) suggests
that with Malaysia’s suburban population, knowledge of the warning symptoms of
colorectal cancer was adequate, though the awareness of colorectal cancer screening
programmes was low, but also a high proportion expressed their willingness to
undergo the screening test. This suggests that raising awareness should be a
priority in Malaysia, through education and media campaigns.
In this study we were not able to consider the lifestyle factors that have been
reported to affect colorectal cancer such as dietary habits (Azeem et al., 2015)
and physical activity (Doubeni et al., 2012b, Tayyem et al., 2013) as we do not
have the data for these variables.
To our knowledge, this is the only study to date that has modelled incidence and
spatial variation of colorectal cancer in Malaysia. The results of this study can
be used to inform those involved in public health; describing the incidence and
Modelling Incidence 159
risk of colorectal cancer in the North-West of Peninsular Malaysia, and predict
the incidence of colorectal cancer in the whole of Peninsular Malaysia.
Our study had several limitations. We only managed to obtain the exact coordi-
nates of addresses for 60% of the cases, the rest were an approximate coordinate.
Future research could address this shortcoming directly using aggregated point
process models (Taylor et al., 2017). A further shortcoming of the study is that
cancer registrations are incomplete, meaning that there is under-ascertainment of
cases. An investigation in to the likely reasons for and levels of this would be
useful. It is also possible to adapt our modelling approach to formally account for
the non ascertainment, though this would not be completely straightforward. The
idea would be to use a censoring-type approach using the ordinary Poisson likeli-
hood for areas with complete ascertainment, like North-West Peninsular Malaysia,
that is:
P(number of observed cases|parameters)
and otherwise,
P(number of cases > observed number of cases|parameters)
This is equal to
1−∑observed number of casesi=0 P (number of cases = i|parameters)
Additionally, our chosen measure of socioeconomic status could be improved, it
could be more spatially resolved. That this measure pertains to large geographical
areas means that care should be taken in interpreting these effects and readers
should be aware of potential ecological bias here. Our measure was derived from
the 2000 census, published by previous study Rahman and Zakaria (2012), whereas
our data involves colorectal cancer cases between 2008 to 2013. Even though we
use the best data available we could have reduced error in our exposure measure
had we had a more up to date and spatially fine metric for socioeconomic status.
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Future analysis could also extend our work into East Malaysia: we were forced to
limit our study to Peninsular Malaysia because of better all-round data quality.
The findings from this chapter shows that urban areas near to the town centres
and health facilities had higher probability of having more colorectal cancer cases
compared to other areas in the states.
Our findings of the incidence prediction for colorectal cancer incidence in Penin-
sular Malaysia shows that the west of Peninsular Malaysia had higher probability
of having incidence which exceeds the national average even though we account
for the additional population there.
One possible reason for increased burden of cancer in urban areas is that people
with a known health condition are more likely to move to be near health care fa-
cilities (Kibele and Janssen, 2013).Likewise, higher incidence in urban areas could
be explained by selective emigration towards diagnosis in towns where healthcare
facilities tend to be diagnosed.
There was a variation in the colorectal cancer incidence in the population. Besides
socioeconomic status and health accessibility that we have discussed, other factors
need to be investigated by the public health authorities regarding why certain
areas had such a high incidence compared to the others. There might be under-
reported cases as we have mentioned earlier that the case ascertainment rate varies
across the country. Furthermore, despite higher incidence in the urban areas,
this population had a better survival according to the findings from our previous
chapter on spatial survival model.
Therefore, the incidence mapping that we produced might help the policy makers
to better plan management to target the places with high incidence as well as
giving more education in the places with very low incidence because of under-
reported cases. Perhaps, more education on cancer prevention and detection is
needed to reach out to the community to improve cancer detection in rural areas
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and to reduce the incidence of colorectal cancer for the whole population. A
further recommendation would be to extend facilities for diagnosis and routine
care to clinics situated outside cities so diagnosis and routine care can be dealt
with in the region of the origin of the patient.
The main findings from this study research relevant to policy makers are:
1. that more funding is required in order to acquire better data on colorectal
cancer, with better geographical information.
2. that from the perspective of trying to understand socioeconomic factors,
more detailed information is required, perhaps an index of multiple depriva-
tion, similar to that used in the UK.
3. that publications involving estimates of colorectal cancer incidence at the
national level should be treated with caution (due to the non-ascertainment
issue)
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Appendix II: Correlation of SE index and proportion of Chinese
Recall that Figure 5.8 the density of the exp(βSEin) and exp(βpCh). This plot was
produced using the kde2d function from the MASS (Venables and Ripley, 2002)
package in R. We show the area that covers 95%, 75% and 50% of the samples.
This contour plot was done using the HPDregionplot from the emdbook (Bolker,
2008) package in R.
Different values of each parameter will give different credible intervals of relative
risk and whether the effect of one factor is significant or not will depend on the
relative risk for the others. We can give relative risks conditional on the other
factor. These are represented in Table 5.8 and Table 5.9. In most cases, the
effect of both variables was not statistically significant, we see that the credible
interval for the conditional risk included 1. For the conditional risk, the effect was
significant for extreme low or high values of the other variable.
Table 5.8: Table of credible interval for relative risk of colorectal cancer in SE
index in conditional to the relative risk for proportion of Chinese















Table 5.9: Table of credible interval for relative risk of Chinese proportion
conditional on the relative risk of SE index






























































Figure 5.13: Contour plot shows the relative risk values for SE index and the
proportion of Chinese. The blue lines show the thresholds at which the relative
risk of each variable was not significant when calculated conditional on the other
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Chapter 6
General Discussion and Further
Research
The research in this thesis focuses on two important parts of the epidemiology of
colorectal cancer: measuring incidence and survival. Our research has addressed
three main areas; identifying the individual prognostic factors for colorectal cancer,
the spatial variation in survival of colorectal cancer and the incidence of colorectal
cancer in Malaysia. This chapter summarises the main points from the findings
of the three objectives of this study, as presented in chapters 3, 4 and 5 of this
thesis.
For the first objective in this research, dicussed in Chapter 3, we investigated
the effects of individual characteristics on the risk of death for colorectal cancer
patients in Malaysia. We analysed data pertainng to over 4412 cases of colorectal
cancer diagnosed between 2008 and 2013 in Malaysia. To our knowledge, this
is the largest study of colorectal cancer survival ever carried out in the country.
Our findings show that survival in colorectal cancer patients depends largely upon
the stage at diagnosis. This is consistent with other studies (Kotake et al., 2016,
Maringe et al., 2013, McKay et al., 2014).
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One particularly concerning aspect was that there was a significant quantity of
missing data in our study; data that involved important predictors such as cancer
staging and tumour differentiation. The ‘education level’ variable had as much as
59% of its records missing.
In Chapter 4, we expanded the first analysis to take into account spatial correla-
tion; we also added area level explanatory variables, namely socioeconomic index
and accessibility to healthcare facilities. Better healthcare provision and higher
socioeconomic index in the districts where patients live decrease the risk of death
from colorectal cancer, but in this study the associations were not statistically
significant. Our findings indicate wide spatial variation in colorectal cancer sur-
vival across Malaysia, after controlling for individual and area level characteristics.
From the map of probability exceedance risk, we notice that a few areas in Kuala
Lumpur, a known aﬄuent city in Malaysia, have a greater probability of high
hazard of death than we might expect. These findings can help policymakers and
health practitioners to identify areas with poor survival outcome. The spatial sur-
vival model that we use can be applied to other diseases to investigate possible
spatial variation and to interpret risk in space.
In Chapter 5, we studied another important aspect of epidemiology: the modelling
of incidence. Accessibility to healthcare, here measured by the number of hospitals
per unit area, positively influenced the estimated number of colorectal cancer cases
in the population but the effect was not significant. The socioeconomic index
and the proportion of Chinese people were positively correlated, but were not
significantly associated with the risk of colorectal cancer. Town centres and urban
areas had a greater risk of having more cases relative to other areas in North-West
Peninsular Malaysia. In our model, we noted spatial variation in the predicted
incidence in Peninsular Malaysia. The western regions of Peninsular Malaysia are
likely to have greater incidence of colorectal cancer than the eastern regions of
Peninsular Malaysia.
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Comparing the incidence and survival of colorectal cancer in Malaysia, we noted
that although the incidence of colorectal cancer in Malaysia is much lower com-
pared to other high income Asian countries such as Singapore and Korea, these
other countries had far greater overall 5-year survival rate (C.M.Oh et al., 2016,
Peng et al., 2013). This is probably due to the late stage of diagnosis in Malaysian
cases, as our study also found that the majority of colorectal cancer patients in our
study were diagnosed at the later stages of disease (stages III and IV). This could
be linked to low socioeconomic status, poor accessibility to healthcare and/or poor
treatment adherence.
Our study was not able to identify a significant effect on either colorectal cancer
incidence or survival from the socioeconomic index and accessibility to healthcare
variables. This may be due to different measurements used in assessing those
factors compared to those used in the literature. In a previous study, they assessed
the individual socioeconomic status with markers such as income and occupation,
while in our study we measured the socioeconomic index for the whole population
of each area; and instead of measuring the spatial distance to healthcare facilities,
we measured the number of hospitals per unit area. Furthermore, apart from the
variables we can control, knowledge and attitude towards screening for colorectal
cancer may also explain some of the variation in survival and incidence of colorectal
cancer in the population. In a previous study, they reported that the Malaysian
population had low rates of participation, knowledge and awareness of screening
for colorectal cancer (Naing et al., 2014, Su et al., 2013, Yusoff et al., 2012). There
could be other factors that might affect the incidence and survival of colorectal
cancer that need to be considered in future research. For example, co-morbidities
(Søgaard et al., 2013) and delay in treatments such as chemotherapy (Xu et al.,
2014) may affect the survival outcome. On the other hand, non-clinical or cultural
aspects such as lifestyle choices, diet and physical activity may be considered as
risk factors for colorectal cancer in future research (Doubeni et al., 2012).
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The main strength of our study is it can be considered as at the forefront of
research in spatial modelling for colorectal cancer in Malaysia, and also that it is
the largest study of its type to date. To our knowledge, this is the only study that
uses spatial survival analysis to model and investigate geographical variation in
the risk of, and predict incidence in, colorectal cancer in Malaysia.
The methods we have used have not been applied to data from Malaysia before. In
particular, incidence of colorectal cancer has historically been difficult to estimate
is South East Asia, but has become less complex and more reliable with the advent
of national population-based cancer registries in the more economically developed
countries in the region such as Japan and Singapore (Sung et al., 2005). Spatial
studies of colorectal cancer, and cancer more generally, have had need of access to
reliable cancer registry data, and these have not been widely available until now.
Estimates of population level incidence rely unlimitedly on the ability to count
accurately the number of new cases of cancer in a time period (a calendar year
commonly) and to have for the same period an accurate estimate of the population
at risk. With reliable census data it is possible to accurately estimate a popula-
tion size denominator, however counting the new cases of cancer is less easy. The
development of the cancer registry system in Malaysia has improved matters and
we have in this study taken advantage of the availability of cancer registry data.
The accuracy of incidence or prevalence estimates based on registry data will be
affected by the accuracy and completeness of the data held and provided by the
registry. In previous analyses of cancer incidence in the region (Sung et al., 2005)
incidence figures were available for nearby countries: Japan, Singapore and Thai-
land, but not for Malaysia. Two points are pertinent here. First, is that out paper
fills a gap in knowledge of the country-level incidence of colorectal cancer. Our
estimate of overall incidence in Malaysia is 2.89 cases/100,000 population/year.
Based on this figure Malaysia’s colorectal cancer incidence is the lowest in South
and South East Asia (see Sung et al. (2005) ).
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Cancer incidence has been increasing in South East Asia. Incidence in aﬄuent
South East Asian countries is now similar to those in the West (IARC,WHO,
2010). This increase had been blamed on a shift in diet and exercise patterns from
traditional to those more common in aﬄuent societies, with higher meat and fat
consumption, and lower levels of vegetable consumption and lower delay calorie
expenditure (Godos et al., 2016). At face value our results would indicate that
the increased in aﬄuent country rates of colorectal cancer have not yet impacted
Malaysia. If that is the case, then, the country should be aware that there is like-
lihood that as aﬄuence increases so will colorectal cancer incidence and measures
should be put in place now to identify and treat cases. Better perhaps, would be
to educate the population to consume a healthy diet and to regularly exercise to
prevent exposures linked to the risk of colorectal cancer (Huxley et al., 2009).
It is possible that our estimate of national rate of cancer incidence underestimates
the true level. This would be so if the completeness of ascertainment of cases is
low. We estimated that the completeness of the registry that provided us data
to be 93% (see section 5.3.5). However, this estimate is based on the premise of
the observed cases, and this is subject to error. Additionally, the accuracy and
reliability of incidence estimate would be improved were we to have had this level
of completeness and been able to use data for all states in the country rather than
for the three we used. The impact on incidence estimates of incomplete registration
can be profound. In England, it is estimated that the national cancer registry is
98-99% complete and that this level of“incompleteness” can lead to inaccuracies
in estimates of survival of around 1% (Møller et al., 2011). If our estimate were
to be nearer the lower 95% credible limit of our estimate, the Malaysian registry
would be missing half of all cases of cancer, with a consequent impact on incidence
estimates.
We have referred elsewhere to the need for a properly national cancer registry in
Malaysia, To improve on this research this is vital. However, cancer registration
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can only work if cases of cancer are diagnosed, and for this a way forward would
be for ore people in Malaysia to come forward to their primary care doctors at
an earlier stage than they do so presently, and for the diagnoses cases of cancer
to be sent from the hospital system into the registry without loss of information.
At that point work such as this can provide the means for the health authorities
to identify how best to reduce risk and subsequent incidence of disease. In this
endeavour, spatial methods such as those used here can be especially useful in
identifying where the risk of exceedance of a set threshold is highest, and thus
where resources can be targeted.
The quality of the data that we receive might affect the results of this study. For
example, two important predictors in our study, education and smoking status had
very high missing values, 59% and 43% of the total cases respectively. These groups
also had higher risk of death compared to the reference group (no-education and
non-smoking), but they were not significant. Based on existing epidemiological
evidence it is likely that these two predictors will indeed affect survival, though
through different causal routes. Had the full data for these variables been available,
the Central Limit Theorem implies we would have been better able to identify the
effect size. Under the additional assumption that higher risk patients (e.g. older,
emergency cases) are less likely to provide these data, and there is some support
for this assumption as detailed in section 3.2.2, we might also expect the effect
size to be underestimated as our parameter inferences (e.g. the effect associated
with being in the lowest education group) were based on a healthier population.
Moving to the spatial model, we did not find a significant effect for the socio-
economic index nor for our measure of accessibility to healthcare on the survival
and incidence of colorectal cancer in the population. It is difficult to predict the
potential change in our estimates of these effects compared to if we had more
reliable information on the associated covariates; this relates to the concept of
ecological bias. Although education group is potentially linked to socioeconomic
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status, it is only part of the picture and does not account for other factors that
might affect SES. To obtain reliable SES data from individuals would require a
range of questions to be answered as part of the initial data entry form. This might
seem an unnatural thing to try to elicit routinely as part of a colorectal cancer
diagnosis by medical practitioners. Similar comments apply to our chosen measure
of healthcare accessibility: again this information would be better obtained from
each patient.
In the future, the following suggestions may improve the quality of data and its
resulting analysis. Reliable measurements of environmental factors are needed to
provide good insight into the effects of potential risk factors for the disease. For
example, a better metric is needed to measure the socioeconomic status and acces-
sibility to healthcare in the country. Ensuring complete, accurate and consistently
recorded data in the National Cancer Registry database is vital for reliable analy-
sis and meaningful results. Perhaps active case ascertainment across the country
and also better training of staff that interact with the database is required in order
to minimise the amount of missing data.
To improve the methodology, two possible extensions can be considered. Firstly,
we can perform the Poisson formal modelling of exactly and inexactly located
cases (Taylor et al., 2017) and secondly, we can use a censoring-type approach to
deal with the cell counts that are being underestimated as discussed at the end of
Chapter 6.
The findings from this study may enlighten both health practitioners and patients
on the subject of colorectal cancer in Malaysia and help policymakers, authorities
and health professionals to develop better healthcare and adequately plan for
disease management in Malaysia. Emphasis on increasing public knowledge of
the risks, symptoms and prevalence of colorectal cancer, together with prominent
campaigns to promote screening, should be a focus for the future.
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